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Acute Diverticulitis is a significant problem, accounting for up to one third of acute surgical 
admissions.  Despite significant and rapid advances in medical knowledge, it remains a poorly 
understood disease.  Practice is influenced by historical studies which have significant flaws.  
Current practice may be a reflection of limitations of the past e.g. the lack of accurate Cross 
Sectional Imaging.  Technology is advancing and historical practices such as routine 
colonoscopy after diverticulitis may not be required.   Risk factors for acute diverticulitis and 
recurrent diverticulitis remain unclear.  With western society changing, diseases such as 
obesity are increasing.   These may have influence on acute diverticulitis, its course and 
recurrence.  Similarly other poorly understood risk factors include use of Non-Steroidal and 
Steroid medications, and the influence of Diabetes and autoimmune diseases.  This thesis is 
an attempt to clarify these questions.  Chapter 1 addresses the historical research and 
evidence that formed the basis of current practice.  In Chapter 2 we address the effect of BMI 
and other risk factors on acute diverticulitis, and found that obese patients may be at 
increased risk.  In chapter 3 we addressed the role of colonoscopy and found that the risk of 
malignancy after a confirmed episode of uncomplicated diverticulitis is not significantly 
different to that of a screened asymptomatic population, while complicated diverticulitis still 
carries a significant risk.  In chapter 4, we looked at recurrent diverticulitis, and found that 
uncomplicated disease at initial presentation, having an autoimmune disease and taking 
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Overview of Diverticular Disease 
1.1 Introduction 
 
Acquired colonic diverticulae, also known as diverticulosis are mucosal outpouchings occurring though 
the wall of the colon.  These occur at areas of weakness in the muscle layer of the colonic wall. It has 
its highest prevalence, and is one of the commonest medical problems affecting western 
populations[1].  It affects 35.3% of New Zealanders over the age of 40[2]. 
 
Diverticular disease represents a spectrum of diseases rather than a single entity.  This ranges from 
asymptomatic diverticulosis, to symptomatic disease.  Symptomatic disease can be further classified 
into uncomplicated and complicated disease.  Uncomplicated disease is usually defined as 
symptomatic disease from inflammation of colonic diverticula.  Complicated disease is usually defined 
and presence of complications of diverticulosis and diverticulitis, including haemorrhage, 
inflammation, perforation, structuring, fistulation into surrounding organs, abscess formation and 
death.   
 
Figure 1 - Definitions 
 
 
Acute diverticulitis is thought to affect up to 20% of patients with diverticulosis[3].  The annual cost of 
diverticular disease was estimated at $USD 2.4 billion per year to the United States (US) alone in 2000, 
and is in the top 5 costliest gastrointestinal disease [4]. These costs are projected to increase. 
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Not all patients with diverticulosis get symptomatic disease.  An estimated 20% of patients get 
diverticulitis.  The majority of these are uncomplicated but a small proportion gets complicated 
disease. 
 




The incidence of diverticulosis is thought to be increasing in western countries.  Associated with this 
there has been significant rises in the incidence of diverticulitis and its complications.  Traditionally 
this disease was thought to affect only older patients.  Increasingly, younger patients are being seen 
with acute diverticulitis.  It was believed that obesity was a risk factor for diverticulitis.  This has never 
been demonstrated in a large scale study, but rather is from the personal experiences of surgeons 
from the turn of the century. There is conflicting evidence regarding this.  We address this in Chapter 
2. 
 
Traditionally, surgery was the mainstay of management of DD.  This has changed significantly over the 
last 20 years, with an increasing shift towards non-surgical management in both the acute and elective 
setting. Improvement in diagnostic techniques such as Computed Tomography (CT) scanning has led 
to greater accuracy in diagnosis of this disease and its complications.  Evolution of non-surgical 
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techniques such as percutaneous drainage of abscess have revolutionised management, allowing 
many patients with abscesses to avoid an operation. 
 
Despite being one of the most prevalent conditions requiring treatment in an acute surgical ward, 
various aspects of this disease remain shrouded in mystery.  Portions of current management exist 
largely because of historical practices rather than sound scientific evidence.  Current guidelines reflect 
limitations of previous technology and management practices.  This includes practices such as routine 
colonoscopy after acute diverticulitis (discussed in chapter 3). 
 
Historically, surgery was recommended after 2 episodes of diverticulitis, as it was believed that 
patients were less likely to respond to medical treatment in subsequent attacks.  Aggressive surgical 
intervention was also advocated in younger patients as they were believed to have more virulent 
disease.  Even up to 2000, surgery after 2 attacks of diverticulitis was recommended[5].   While some 
guidelines still endorse these practices, they have been largely abandoned.  The role of surgery in an 
elective setting after diverticulitis remains unclear.  While surgery does provide relief from recurrent 
episodes in a single affected segment, when to proceed to resection remains an unknown and highly 
contentious issue.  The decision to operate relies heavily on knowledge of the natural history of 
diverticulitis and factors that influence this. However, to date there are many aspects of the natural 
history of the disease that remain unclear.  It has been known for a while that a portion of patients 
get recurrent diverticulitis.  There is a significant paucity of literature on risk factors that predict for 
recurrence.  We address this issue in Chapter 4.   
 
2. History  
 
2.1 History of Diverticular Disease 
 
 
The word diverticulum comes from the Latin “Diverto” or “to turn aside or divert”.  A diverticulum 
therefore is a small turning aside.   Abnormalities of the intestinal tract have been described by various 
authors, including Sommering, Schrock, Riolan etc without any clear differentiation of specific 
pathology[6]. 
 
The French anatomist Alexis Littre was probably the first to accurately intestinal diverticula in 1700. 
He believed that diverticula formed due to traction on intestinal wall due to part of the wall entering 
a hernia sac. He believed this resulted in the wall of the intestine being pulled out, resulting in 
diverticula [7]. He however did not differentiate colonic from other diverticula.  
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Giovanni Morgagni in 1761 recognised that not all diverticula could be related to traction, and said 
“for sometimes they belong to those intestines which area not situated in places where hernias 
happen”[8]. He recognised ileal diverticula separately in humans as well as geese, and hypothesized 
that these could be related to the vitellum.   While he believed in Littre’s view of traction on the bowel,  
also believed in the views of Fabricius, that bowel content became harder and dryer as it progressed 
along the intestine, and exerted pressure from inside. He thought that this could also contribute to 
formation of diverticula.  
 
Johann Meckel in 1812 described a protrusion in the ileum. He was the first to show that this 
diverticulum was formed congenitally, and not as a result of traction.  He recognised this occurred 
only in the ileum, and recognised that it contained all layers of intestinal wall[8].  
 
Colonic diverticulae were probably first described by Voigtel in 1804[9].  He said that it was not rare 
to find bags or sacks in the colon. He called these “Natüriche Anhängsel am Darmkanal” or “Naturally 
occurring appendages of the Intestinal Canal”.  It is not clear however whether these were colonic 
diverticulae.  Similarly Fleischmann in 1815 gave a description of diverticulae in the gastrointestinal 
tract, including bile duct and colonic outpouchings[10].  Again, he did not differentiate colonic from 
other diverticula. He was the first to use the term “Divertikel”   
 
Monro in 1830 described diverticulitis causing death of a patient.   He have a clear account, writing 
“the term diverticulum is to be understood a process of blind sac connected to the convexity of a 
portion of the intestinal canal which fully communicates with the cavity of the intestine excepting 
when inflammation has given rise to accretion of their opposite side”[11].   
 
While this may have been the first description of diverticular disease, credit for the first accurate and 
clear description of colonic diverticula is usually attributed to the French anatomist and pathologist 
Jean Cruveilhier in 1834[8, 11, 12].   He performed multiple post mortem studies on human cadavers, 
and published the two volume Anatomie pathologique du corps humain in 1835.   He wrote ‘we not 
infrequently find between the bands of longitudinal muscle fibers in the sigmoid a series of small, dark, 
pear-shaped tumours, which are formed by herniae of the mucous membrane through the gaps in the 
muscle coat”[9].  He called these “hernies tuniquaires” or hernias related to the tunica of colon.  He 
was the first to use the term diverticulum and grouped them into congenital and acquired, without 
describing any difference in structure.   
 
In 1896, the German anatomist Graser observed that diverticulae were associated with entrance or 
exit of blood vessel in the wall of the intestine[13]. He believed that areas of weakness occurred in the 
bowel wall where veins entered the colon. As veins are capacitance vessels needing to distend, space 
was needed around these vessels, leading to weakness.  He thought that obstruction of drainage of 
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blood via the inferior mesenteric artery predisposed to weakness in the colonic wall and formation of 
diverticulae[9].   This was propounded by Sudsuki, who found venous congestion in 6 out of 15 cases 
of acquired diverticulae[14].   Graser was the first described the phenomenon of diverticulitis, or 
inflammation of a diverticulum, what he termed peri-diverticulitis.   
 
Other anatomists and pathologists described diverticulosis and diverticulitis between 1850 and 1900 
to varying degrees, including Klebs[15], Heschl[16], Hanau[17], Good[18], Hansemann[19] and 
Fischer[6].  Klebs reported that number of diverticulae were higher in obese patients, while 
Hansemann reported a higher number in lean people.  Heschel, Hanau and Good attempted to 
recreate diverticulae by filling human cadaveric intestines with water under pressure and recording 
points of rupture. They concluded that the weakest part of the bowel was at the mesenteric border, 
where vessels from mesentery penetrated into colon.  Chlumsky in 1899 attempted to replicate this 
experiment in live intestines of dogs[20]. He found in live animals, ruptures occurred more frequently 
at the anti-mesenteric border, whereas once the intestine was removed and dead, ruptures occurred 
in the mesenteric border.  Despite this, the belief of the time was that DD occurred at the 
antimesenteric border due to high luminal pressures.  
 
Figure 3 - Relation of blood vessels to diverticulae 
 
From Painter (1970)[21] 
 
In 1904 Edwin Beer described complications of diverticular disease in 18 cases, including diverticulitis, 
abscess formation, stenosis and structuring, perforation, ulceration, fistula formation, as well as 
cancer.  He tried to differentiate diverticulitis from malignant disease, and believed they were often 
mistaken.   He recognised that the incidence was increasing, writing “Only 20 years ago Virchow spoke 
of acquired diverticulae as an unusual pathological condition, but during these 20 years our views have 
changed”[22]. 
 
In 1927 Spriggs and Marxer first attempted to identify the aetiology of diverticular disease.  They 
classified diverticular disease into 4 stages based on appearances at Barium Enema[23]. It was 
believed that formation of diverticular disease progressed though these stages. Stage 1 was the 
“Prediverticular Stage” where there was loss of normal segmentation of the bowel. Stage 2 was the 
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“Stage of Irritation” where early diverticulae could be seen, and the bowel itself had a “concertina-
like appearance”.  Stage 3 was “Developed Diverticula”, where various diverticulae of various shapes 
and sizes were visible. Some contained all the coats of the bowel wall, while others had loss of muscle 
fibers. Often the diverticula had stercoliths. Stage 4 was “Diverticulitis”, where inflammation arose 
from the neck of the pouches, especially those containing stercoliths.  According to the thinking at the 
time, formation of diverticulitis was inevitable, due to relentless progression of the disease though 
the stages.  
 
As treatment, Spriggs recommended a healthy diet with fruit and vegetables.  He also writes “The 
colon is washed out with saline every other day, for a time, but at low pressure, the funnel being not 
more than 18 inches above the level of the anus”. He also writes “If grave symptoms such as a rising 
pulse rate, collapse, and intractable vomiting are not present, and the diagnosis has been made 
radiologically, then castor oil (with laudanum) and hot fomentations and enema may be given with 
confidence”. He advocated surgery only for the complications of diverticular disease[23]. 
 
Lockhart-Mummery, while writing on the aetiology of diverticular disease in 1930, did not believe in 
the progressive stages of diverticular disease[24]. He writes “The secondary inflammation may never 
occur, or it may take place at almost any stage in the development of the pouches”. He also 
commented that he seldom saw thin people with diverticulitis.  
 
The next stage in the search for aetiology of diverticular disease came in the 1960’s.  Attention was 
turned towards the luminal pressure of colons with diverticulosis.  In 1962 Painter reported the first 
study of intraluminal pressures in diverticulosis to the British Society of Gastroenterology [25]. He 
found that administration of morphine resulted in increased frequency and higher amplitude pressure 
waves in sigmoid colons with diverticular disease, and concluded that morphine should not be 
administered in diverticulitis.  
 
Subsequently in 1964, Painter[26-30] and Arfwiddsen[31] published studies measuring intraluminal 
pressures in diverticular disease. Painter, in a 4 part study found that under basal conditions, the 
intraluminal pressures were not different in the sigmoid colon with and without diverticular disease. 
In the presence of morphine and neostigmine however, the frequency and amplitude of pressure 
waves were much higher in colons with diverticulosis.  When the muscle was paralysed by 
probanthine, the intraluminal pressures fell to a basal level in colons with diverticulosis, even with 
provocation.  He concluded that morphine should be contraindicated in acute diverticulitis. 
Arifwiddsen showed that segments of the sigmoid colon with diverticulosis were capable of producing 




Attention was then turned to the muscular layer of the colon.  Morson in 1963 showed that the pain 
experienced by patients in acute diverticulitis was most probably not due to inflammation[32]. He 
showed that about two thirds of cases of diverticulitis that underwent resection had no evidence of 
inflammatory disease in the pathological specimen.  These instead had a significant degree of muscular 
thickening in the wall of the colon. Hughes in 1968 examined colons of 200 unselected cadavers and 
measured muscle thickness in the colon wall[33]. He found muscle wall thickening or abnormality 
present in 73% of colons with diverticula, and in only 8% of those colons without.  He also noted that 
all cases with acute diverticulitis at the time of death showed marked muscle thickening.   
 
This combined with the findings of Painter and Arfwiddsen led to the theory that diverticulosis was 
caused by pulsion of colonic mucosa by excessive intraluminal pressure. Due to muscular hypertrophy, 
excessive intraluminal pressures could be generated. During segmentation, the outflow of the colon 
is obstructed leading to a pocket of high pressure, causing pulsion of diverticula at areas of weakness.  
Because the underlying cause was thought to be due to muscular hypertrophy, this lead to the 
development of myotomy as an alternative to resection in diverticulitis[34].   
 
Others however had different findings in colons with DD. Edwards in 1934 showed that in the 
“prediverticular stage”, the circular muscle of the colon developed ridges[35]. This resulted in an area 
between the ridges where the muscle coat was thin enough to allow close approximation of mucosa 
and serosa.  He proposed irregular muscle spasm as a mechanism, leading to variability in muscle 
thickness.  
 
Painter was also among the first to propose a dietary causation[36].  Amongst his travels he had noted 
that the incidence of DD was extremely low to non-existent in Sub-Saharan African populations as well 
as in the Pacific. He proposed a role for dietary fibre.  He noted that during the years of World War II, 
the crude death rate from DD was stable.  During this period due to scarcity of resources, the bread 
available was less refined and higher in fibre.  Refined sugar was strictly rationed.  After the war years, 
the mortality from DD steadily increased.  Painter states that “Diverticulosis, like scurvy, is a deficiency 
disease, and therefore, should be preventable”[37].   
 
Correlation however does not equal causation.  There have been multiple studies reporting relatively 
low prevalence in geographical areas with high fibre diet.  This is addressed later in this chapter.  There 
are significant ethnic and regional variations as well, independent of diet.   
 
Despite its prevalence, our understanding of the pathophysiology of DD has not improved appreciably 
for the past 30 years.  
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2.2 History of Surgery in Diverticular Disease 
 
The first successful resections of diverticulitis was reported by Moynihan in 1907[38].  He described 
abdominal operations as “martyrology”, as two thirds of all patients died after abdominal section.  In 
describing diseases of the large intestine, he describes “mimicry of malignant disease”.  He reported 
operating on a patient with suspected carcinoma, “examination of which subsequently revealed no 
evidence whatsoever of a malignant grown”.  He then describes the specimen as “A hyperplastic 
tuberculous tumour, dense inflammatory deposits on the serous covering, or the formation of many 
false diverticula with inflammation in and around them”.  Later that year William Mayo and colleagues 
reported operating on 5 patients with strictures related to diverticular disease[39]. Mayo conjectured 
that diverticulosis resulted from a congenital defect in the muscular layer of the colon. 
 
Smithwick in 1942 reporting experience with management of diverticular disease at Massachusetts 
General Hospital advocated an aggressive surgical approach to diverticular disease[40].  He described 
it as a comparatively rare disease.  His data showed that roentgenologic evidence of diverticulitis was 
present in 25% of cases having diverticulosis.   Of the patients with diverticulitis, medical management 
was unsatisfactory and unmanageable in 9.3% of patients. Of the patients operated on, 40% had 
perforation or fistulation into the bladder.  An operation was required in 48% of all first attacks of 
diverticulitis. He compared different procedures, and reported best results from either proximal 
diversion or resection of the affected segment.  He reported an overall mortality of 17.1%.  
  
By 1955, with the introduction of better anaesthetic techniques, antibiotics and aseptic technique, the 
mortality of intestinal operations had reduced to about 5%.  Todd in the Hunterian Lecture to the 
Royal College of Surgeons in England recognised the difficulties in operating on dense fixated fibrosed 
inflamed colons[41].  He described proximal diversion of the colon, or as he called it “Preliminary 
Colostomy”.  He writes “Preliminary colostomy, placed well in the right half of the transverse colon to 
leave a long distal loop free for later resection and anastomosis, is advisable in all cases of complicated 
diverticulitis and also in those cases where symptoms or even a mass do not show rapid improvement 
with conservative therapy and chemotherapy”.  Once the acute attack was treated, a delayed 
resection six to eight weeks down the track was performed. He also noted “Almost all the patients are 
fat.”  Of the 29 operative cases described by Todd, only one death was reported, from undiagnosed 
bilateral pyelonephritis. 
 
Up to this point, surgery in diverticular disease was reserved for complication of diverticulosis. In 1969, 
Parks published a seminal paper on the natural history of diverticular disease[42]. He reported a 
readmission rate of 24.6% in patients treated medically on their first admission for diverticulitis.  Of 
the ones treated surgically he writes “The 138 patients who were surgically treated as a result of the 
presenting attack had a variable number of admissions, mostly related to staged procedures and are 
not further considered here”.  He believed that progress of disease was more often within one 
segment rather than involving progressive segments.  Parks reported that medical treatment was less 
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likely to be successful in subsequent attacks and that mortality increased significantly once patients 
developed complications of diverticular disease.  His data showed only a 6% chance of success with 
medical treatment after the third attack. Based on this, surgery was recommended after 2 attacks of 
acute diverticulitis.  This was the prevailing practice for the next 4 decades, despite the questionable 
findings and paucity of evidence.  
 
In 1964 Reilly introduced Sigmoid Myotomy as an alternative to resection[34]. He reported performing 
a longitudinal myotomy on 8 patients. Unfortunately, the first 2 patients who underwent this 
procedure died immediately after the operation, the first within 24 hours of coronary thrombosis, and 
the second at day 10 of pulmonary embolism. In 1970 he published 5 year results of treating 50 
patients with myotomy and found that 42 patients had a “satisfactory” result[43].  This was initially 
taken up enthusiastically as a therapeutic as well as a preventative procedure.   Reilly’s results 
however could not be replicated in subsequent studies.  Studies also showed recurrence of high 
intracolonic pressures after myotomy[44], as well as recurrent diverticulitis[45].  While still performed 





Diverticulosis affects a significant proportion of the population.  The exact prevalence varies as 
discussed below.  Not all diverticulosis is symptomatic, nor does all diverticulosis lead to acute 
diverticulitis.  The incidence of diverticulosis increases with age.  There are also significant ethnic, 
regional and gender variations in incidence of diverticulosis.   
 
3.2 Epidemiology of Diverticulosis 
 
3.2.1 Prevalence of Diverticular Disease 
 
The exact prevalence of diverticulosis is not known.   As about 80% of patients affected with 
diverticulosis are asymptomatic, the true prevalence of this disease can be difficult to ascertain.  The 
risk of diverticular disease increases with age.  It is estimated that up to 65% of people greater than 
65 years old in industrialised countries have colonic diverticulae [21].  
 
The prevalence of diverticular disease has been determined indirectly from radiological, autopsy 
studies and clinical studies including endoscopy.   There are problems with each method of evaluation.   
The sensitivity and specificity of each test varies. Many studies were performed on a small number of 
patients, at a single institution or single geographical area.  These results may not be a true reflection 
of incidence in the overall population.   The inclusion criteria for patients into each study varied, as did 
the age of the population studied. 
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A summary of studies reporting prevalence of diverticular disease is shown in Table 1.  The first  
radiological study looking at prevalence was performed by Spriggs and Marxer in 1925[10].  They 
looked at 1000 consecutive barium enemas, and found presence of colonic diverticulae in 10%.   In 
1930 William Mayo reported diverticulosis in 5% of autopsies at their clinic[12].  He thought about 
12% of cases of diverticulosis developed diverticulitis. Rankin and Brown reported an incidence of 
5.7% in 24,620 Barium enemas[46].    More recent studies have reported a much higher prevalence, 
ranging from 30 to 50%.  It has been known for a long time that the incidence increases with age.   
Even correcting for age, there has been a shift towards increased prevalence over the past century.  
 
Table 1 - Reported Prevalence of Diverticular Disease 
Year Study Location Method Patients Overall Prevalance 
1925 Spriggs [10] Wales, UK Barium Enema 1000 10% 
1930 Mayo[12] Rochester, US Xray Colon 
Autopsy 
31,838 5.71% 
1930 Rankin and Brown[46] Rochester, US Barium Enema (24,620) 
Autopsy (1925)  
 5.67% 
5.2% 
   Autopsy 1925 5.2% 
1935 Ochsner [47] Rochester, US Autopsy 447 6.9% 
1947 Pemberton[48] Rochester, US Barium Enema 47,000 8.5% 
1946 Morton[49] Rochester, US Autopsy 8500 6.5% 
1948 Cleland[50] Adelaide, Australia Autopsy 3000 2.8% 
1949 Grout[51] UK Barium Enema 2179 8% 
1953 Welch[52] Massachussets, US Barium Enema 2000 33% 
1959 Havia[53] Sweden Barium Enema 3563 15.8% 
1961 Havia[53] Finland Barium Enema 3125 5.2% 
1969 Havia[53] Finland Barium Enema 
Laparotomy 
1215 12% 
1967 Manousos[54] Oxford, UK Barium Enema 109 7.6%<60 
34.9%>60 
1964 Kim[55] Korea Barium Enema 1500 0% 
1967 Suarez[56] Puerto Rico Barium Enema 971 1% 




1969 Stemmerman[58] Hawaii, US Autopsy 202 52% 
1971 Eastwood[59] Edinburgh UK Barium Enema 12,335 22.9% 
1974 Levy[60] Israel Barium Enema 1377 16.2% Ashkenazi 
3.8% Sephardic 
0.7% Arab 
1984 Levy[61] Israel Barium Enema 880 17.3% Ashkenazi 
12.3% Sephardic 
5.4% Arab 
1974 Bohrer[62] Nigeria Barium Enema 216 1.15% 
1975 Narasaka[63] Japan Barium Enema 2662 1.7% 
1975 Rios-Dalenz[64] Bolivia Barium Enema 500 0.2% 
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1976 Sato[65] Japan Autopsy 771 1% 
1976 Eide[66] Norway Autopsy 280 32.1% 
1978 Archampong[67] Ghana Barium Enema 592 3.9% 
1978 Calder[68] Kenya Barium Enema 226 6% 
1978 Marigo[69] Brazil Autopsy 832 9.5% 
1979 Rolon[70] Paraguay Autopsy 1364 0.73% 
1979 Eide[66] Norway Autopsy 280 32.15% 
1980 Vajrabukka[71] Thailand Barium Enema 289 4% 
1981 Dabestani[72] Iran  Barium Enema 690 1.6% 
1981 Bohrer[73] Guatemala Barium Enema 300 2% 
1982 Sim[2] New Zealand Barium Enema 1118 35.3% 
1982 Nakib[74] Kuwait Colonoscopy 481 0.6% 
1982 Kubo[75] Japan Barium Enema 12,505 7.8% 
1983 Fatayer[76] Jordan Barium Enema 274 4% 






1985 Burkitt[78] Georgia, US Barium Enema 277 52-60% 
1985 Ogunbiyi[79] Nigeria Barium Enema 603 1.85% 
1985 Coode[80] Hong Kong Autopsy 200 5% 
1986 Lee[81] Singapore Autopsy 1014 19.1% 
1987 Ihekwaba[82] Nigeria Autopsy 1420 0.01% 
1987 Sugihara[83] Japan Barium Enema 625 13.3% 
1987 Naraynsingh[84] Trinidad Barium Enema 971 24.6% 
1991 Yap[85] Singapore Barium Enema 361 28% 
1991 Chia[86] Singapore Barium Enema 524 20% 
1993 Munakata[87] Japan Barium Enema 11,084 23.2% 
1995 Nakada[88] Japan Barium Enema 6849 15.7% 
1998 Ogutu[89] Kenya Colonoscopy 247 5.3% 
1998 Chan[90] Hong Kong Barium Enema 858 25.1% 
2000 Miura[91] Japan Barium Enema 13947 28.3% 
2010 Lee[92] Korea  Colonoscopy 1030 19.7% 
2010 Song[93] Korea Colonoscopy 848 12.1% 
2011 Rondagh[94] Netherlands Colonoscopy 2310 37% 
2011 Prilepskaia[95] Moscow, Russia Colonoscopy 300 16.2% 
2011 Elbatea[96] Egypt Colonoscopy 864 2% 
2011 Golder[97] UK Barium Enema 1000 44.7% 
2012 Kamalesh[98] India Colonoscopy 3022 9.9% 
2013 Azzam[99] Saudi Arabia Colonoscopy 3649 7.4% 
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There are significant and interesting regional variations in reported prevalence of diverticulosis.   
Diverticulosis is almost unheard of in certain South American states and in Africa. Recent studies have 
reported an increasing incidence of diverticulosis in Africa.  Despite this, the reported incidence of 
diverticular disease in African and middle eastern countries remains  much lower than that in western 
countries.  There are interesting regional variations.  Levy et.al. looked at the incidence of 
diverticulosis in various ethnic groups in Israel  in 1974, and a follow-up study in 1984[60, 61]  . He 
found that the incidence did not change in significantly in the Jewish population, but increased 5 fold 
in the Arab population. The cause of these regional variations is as yet unknown, and is potential areas 
of future study. 
 
3.2.2 Effect of Age and Gender 
 
It has been known for a long time that the prevalence of diverticulosis as well as the incidence of 
diverticulitis increases with age.  William Mayo noted that diverticulosis was rare in younger patients.  
In his series of 1819 patients in the 1930’s, only 20 patients were less than 40[12].   Multiple series 
since then have reported prevalence of 2-5% in patients less than 40, increasing to up to 60% in 
patients more than 70[100].  This is independent of regional variations.    
 
Earlier studies reported a male preponderance in the incidence of diverticulitis.  More recent data 
shows a female preponderance.  A large series from 1974 to 1983 of symptomatic diverticulitis 
admitted at Massachusetts General Hospital showed 59.1% of all cases were Female[101]. In patients 
under 50, men predominated, but in patients over 50, women were predominant. Other studies have 
also shown a predominance of men in younger patients [102, 103].  
 
Figure 2 shows incidence of diverticulosis with respect to region, age and gender.  Correcting for 
regional variations, there is still an increase in incidence of diverticulosis with increasing age in 
Western Countries. In Singapore, the prevalence peaked at 65-74, and then decreased in older 
cohorts.   
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Figure 4 - Prevalence of Colonic DD by Age, Gender and Region at Autopsy 
 
From Commane et. al. [104] 
 
3.2.3 Regional and Ethnic Variations 
 
There are significant ethnic as well as regional variations in the incidence of diverticulosis and 
diverticulitis.   In a seminal paper published in 1969 by Painter, Diverticular disease was called a disease 
of Western Civilisations[37].  This stemmed from his experiences in Africa, where Painter had noticed 
that diverticular disease was almost unheard of.   
 
South American countries have very low reported incidences of diverticular disease and its 
complications.  Reported incidence included 0.2 %in Bolivia[64], 1% in Puerto Rico[56] and 0.73% in 
Paraguay[70].  An interesting study conducted by Bohrer on the highland Mayan Indian tribes in 
Guatemala reported an incidence of 2%[73].   Their diet and lifestyle were reportedly were largely 
unchanged with Western influence.  A study from Brazil reported a higher incidence of 9.5%[69].  
While this was much higher than other South American countries, it was still significantly lower than 
that of western countries.   
 
Middle Eastern countries also have very low reported incidence of diverticular disease. In a study from 
Iran, Ghavami reported no diverticular disease found from almost 4000 patients[57].  Another study 
by Dabestani from Iran reported an incidence of 1.6%[72].  Other reports included an incidence of 
0.6% in Kuwait[74], 2% in Egypt[96], 4% in Jordan[76]and 7.4% in Saudi Arabia[99].  
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The incidence of diverticular disease in Africa traditionally has been of great interest.  This was the 
region that Painter initially noticed a very low incidence[36].   He reported that diverticular disease 
was almost unknown in rural Africa, and seen only occasionally in more in 40 hospitals in Johannesburg 
and in Ibadan, Nigeria.  Studies from the region report an incidence of 6% in Kenya[68], and 3.9% in 
Ghana[67].  There have been multiple studies conducted in Nigeria.  Bohrer reported an incidence of 
1.15% in a tribe in rural Nigeria[62].  Ihekwaba reported an incidence of 0.01% from an autopsy series 
on “Black Africa” in Nigeria[82].  Ogunbiyi conducted a study in Ibadan, the area initially reported by 
Painter, and found an incidence of 1.85%[79].   Alatise et al reported only 40 cases of diverticular 
disease over a 5 year period in a tertiary hospital in Nigeria[105].  
 
As immigration increases from non-western countries to western countries, the incidence of 
diverticulosis in these migrants has been studied.  Migrants have been noted to have lower incidence 
for diverticular disease than native residents of western countries.  Painter reported that the disease 
was rare amongst Japanese, but increased in Japanese migrants in Hawaii.  He also noted that the 
incidence of diverticular disease and diverticulitis in Negro Americans was equivalent to that that of 
their white counterparts, while the disease was almost unheard of in Africa.   Turkish migrants to the 
Zaanstreek region of Netherlands have a significantly lower incidence of diverticular disease (7.5% vs 
50%)[106].  Similarly, incidence of diverticular disease among Indian subcontinent migrants to UK is 
also significantly lower than that of native residents (6% vs 23%)[107].   
 
Hjern et al looked at hospitalisations for diverticular disease amongst immigrants over a 10 year period 
in Sweden[108].  After adjusting for age, sex and socioeconomic status, they found that incidence of 
diverticular disease  among migrants from Western Europe, Australia, New Zealand and North America 
were not significantly different to that of the native Swedish population.  Amongst migrants from Non 
Western countries, including Africa, Asia, South America and Eastern Europe, there was initially a 
much lower risk of admission.  However, their incidence of diverticular related admissions increased 
sequentially the longer they lived in Sweden. No study has specifically looked at differences in diet 
among migrants or ethnic groups. 
Figure 3 shows a graph of reported prevalence of DD over time in some countries.  All countries except 
Jordan and Kenya showed an increase in prevalence.  The largest rise was reported in Japan, where 
prevalence went from <5% in 1975 to 28% in 2000. 
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Figure 5 - Reported prevalence of diverticulosis over time in countries 
 
From Jun et. al., 2002[109] 
 
3.2.3.1 Asian Countries and Right Sided Diverticular Disease 
 
Asian countries have been studied with great interest as the spectrum of disease is quite different to 
that of western countries.  In western countries, diverticular disease affects the left side of the colon 
90-99% of the times[97]. In Asian countries, diverticular disease is predominantly on the right side.  
Right sided diverticular disease is found in about 20% of asymptomatic patients in Asian countries vs. 
only about 5% in western countries.  In western countries, diverticulitis involves the right side only 
about 1.5% of times vs. 75% in Asian countries[110].  The cause of this difference in distribution has 
not been explained to date. Within Asian countries, there are interesting variations.  
 
In Singapore, autopsy data from more than 1000 patients showed a significantly higher incidence 
amongst ethnic Chinese (24%) compared to ethnic Indians (14.3%) and Malays (11.7%)[81].   They 
found that if a single diverticulum only was found, it was found in the right colon or transverse colon 
87.1% of times.  For multiple diverticulae, the right side was involved 67-95% of the times.  This is in 
sharp contrast to distribution of disease among western countries, where right sided disease is found 
very rarely.  Interestingly, the distribution of right sided disease was similar in all three ethnic groups 
studied.  While there were ethnic variations in overall incidence, there was no significant difference 
in the distribution of the disease.  This suggests an environmental factor predisposing to right sided 
disease.  
 
An autopsy series from Japan, looking at 625 patients found right sided diverticular disease in 
68.8%[83].  Of the 77 patients with diverticulitis in this series, 61 (79.2%) had right sided diverticulitis 
while only 16 (20.8%) had left sided disease.   A South Korean study of 1030 patients undergoing 
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colonoscopy at a tertiary hospital in South Korea found diverticulosis in 203 (19.7%) of patients[92].  
Of these 203 patients, Right sided diverticulosis (i.e. involving caecum and ascending colon) was found 
in 85%. The Left side was involved only 12.7% of the times.  This distribution was also reflected in the 
incidence of diverticulitis.  About 80% of the cases of diverticulitis were on the right side. There have 
also been multiple longitudinal studies looking at diverticulosis in Japan in from 1967 to 1993 [83, 87, 
88].  This showed a significant increase from 2.1% in 1967 to 23% in 1993. 
 
The cause of this East-West difference has not been explained.   Studies on Japanese emigrants to 
Hawaii, and their children have shown a right sided predilection, compared to the indigenous 
Hawaiian population[58, 111].  This suggests a genetic predisposition as well as environmental factors 
in the pathogenesis.  This is a potential area for future study. 
 
3.3 Pathogenesis of DD 
 
3.3.1 Introduction 
The exact mechanism by which DD forms is as yet unknown.  Rather than a single causative factor, 
multiple factors have been identified.  Diverticular disease probably results from a complex interplay 
of Genetic, Lifestyle and Enviromental factors.  There may be a difference in aetiology of right sided 
disease vs left sided disease.  In the western world left sided disease predominates, therefore our 
discussion focuses on this.   
 
There are functional differences between the right and left side of the colon.  The right colon receives 
ileal content, which is predominantly liquid.  It has a relatively high concentration of carbohydrates 
and proteins that have escaped small bowel digestion.  As this content moves through the colon, 
bacterial action causes fermentation and solubilisation.  Further down the colon, the level of microbial 
action decreases as substrate for activity decreases.  Coupled with this there is increase in absorption 
of water and electrolytes, resulting in a firmer content.  By the time it reaches the descending colon, 
most of the absorption will have occurred.  The sigmoid colon and rectum act as a holding reservoir 
for the bulk.  As we progress distally from the sigmoid colon, the level of voluntary control increases, 
allowing for control of release of faecal matter. 
 
The wall of the colon is composed of 3 layers, namely, the mucosa, muscularis, and serosa.  The 
muscularis layer is composed of 2 layers of muscles, named after for their orientation in the colonic 
wall, i.e Circular and longitudinal layers.  The circular muscle layer thickens at regular intervals to form 
valvular flaps, called plicae circularis, that project into the lumen of the bowel.  These act to slow down 
passage of effluent, as well as to increase absorptive area available.  The longitudinal muscle layer also 
condenses into thick bands called the taeniae coli.  This contracts to allow shortening of the colon 
which results in forward propulsion of content. 
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Historically models of pathogenesis include the staged model and herniation in areas of vascularity.  
These were discussed previously in the history of DD.  The staged model has now been abandoned, 
and it is now known that DD can involve any portion of the bowel, and not just the mesenteric side 
with blood vessels.   
 
3.3.2 Summary of Proposed Models of Pathogenesis for Diverticular Disease 
 
3.3.2.1 Smooth Muscle Hypertrophy and Role of Elastin, Collagen, MMP and TIMP 
 
Thickening of the Smooth Muscle layer has long been recognised as one of the most consistent 
features of diverticular disease[33, 112].  This was thought to be due to increased muscle hypertrophy, 
resulting in increased intraluminal pressures and subsequently, diverticular disease.  It is now known 
that this is incorrect.  Ultrastructural studies of the muscle cells of patients with uncomplicated DD 
have not shown hypertrophy or hyperplasia of muscle cells.  Instead, studies have shown an increase 
in elastin laid down between muscle cells, resulting in altered muscle morphology.  These changes are 
not unique to DD, as they have also been found as a natural feature of ageing[113, 114].  
 
A role for collagen has long been suspected in the pathogenesis of DD and diverticulitis.  Collagen Type 
I is responsible for mechanical strength in mature tissue.  Collagen Type III is usually found in early 
phases of wound healing, and does not have the same tensile strength of Type I.  Collagen is degraded 
by the synergistic action of Matrix Metalloproteinases (MMP), a family of zinc-dependant 
endopeptidase enzymes, and Tissue Inhibitors of MMP (TIMP).  Colonic diverticula occur as a result of 
weakness in colonic wall, resulting in outpouchings of the mucosa and submucosa.  Weakness of 
colonic wall could be the result of reduced Type 1 collagen, either from reduced deposition or from 
increased action of MMP and TIMP.  Weakness could also result from increased deposition of Type III 
collagen. 
 
Deposition of collagen in muscle layers has also been shown in patients with DD[115]. Studies of ratios 
of Collagen Type I to Type III in patients with DD have shown increased Type III collagen compared to 
colons free of diverticular disease[116, 117].  As Type III collagen is usually laid down after 
inflammation, this suggests inflammation and scarring in the pathogenesis.  Increase in elastosis by 
greater than 200% as been shown in taenia coli of patients with DD[118].  Increased collagen 
crosslinking resulting in a less compliant colon has also been shown in patients with DD[119] 
 
Studies of MMP and TIMP in patients with diverticulitis have been conflicting. Stumpf et.al. showed 
decreased expression of MMP[117], while Rosemar et.al.[120] found increased expression.  Mimura 
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and colleages found an 18 fold increase in TIMP mRNA expression in complicated diverticulosis 
compared to controls[121].  This upregulation of TIMP was also observed in Macrophages and 
fibroblasts in areas around blood vessels.  Increased TIMP expression has been associated with 
increased severity of diverticulitis[121].   
 
These studies have been conducted on a small number of patients who have undergone resection for 
acute diverticulitis.  Whether these factors play a role in the formation of asymptomatic DD is 
unknown.  In acute diverticulitis, there is increased expression of cytokines and pro-inflammatory 
mediators, which may alter expression of mRNA of MMP and TIMP’s[122].  It is also not known 
whether the increased ratio of Type III collagen is a result of previous bouts of inflammation or as a 
result of an acute process.  
 
3.3.2.2 Genetics and Connective Tissue Disorders 
 
There is evidence that weakness in connective tissue such as elastin and collagen can result in 
diverticular disease.  The incidence of diverticular disease and diverticulitis is increased in patients 
with congenital disorders of elastin and collagen.  Patients with Congenital Connective tissue disorders 
such as Marfans Syndrome and Ehlers Danlos Syndrome have an increased incidence and present at a 
younger age with diverticulosis and diverticulitis[123, 124].  Colonic diverticulae are present in up to 
40% of patients with Ehlers-Danlos Type IV syndrome[125].  Perforated diverticulitis has also been 
described in adolescents with Williams-Beuren Syndrome, leading to operative intervention[126].  
Diverticulosis is also present in high numbers in patients with Polycystic Kidney Disease on dialysis 
compared to renal failure patients without Polycystic disease and age matched controls [127]. 
 
3.3.2.3 Intraluminal Pressure , Colonic Transit Time (CTT), and Colonic Motility 
 
 
While traditionally believed to the primary causative agent in the formation of DD, studies looking at 
intraluminal pressures and CTT have been conflicting and contradictory, and plagued with 
methodological flaws.   
 
Burkitt in 1972 studied CTT, stool weight and dietary intake in UK, South Africa and Uganda. He found 
that increased fibre in diet resulted in shorter CTT and increased stool weight [128]. He hypothesised 
that low fibre resulted in smaller harder stools that took longer to pass through the colon, which 
resulted in the colon generating higher pressures to propel and expel stool.  He proposed this as the 
underling mechanism for DD.  Seminal work by Painter and Arfwiddsen also suggested a role for 
increased intraluminal pressures [26-31].    
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The evidence for the role of abnormal intracolonic pressure is weak.  These studies generally did not 
control for age or gender, and they were performed on small number of patients, without adequate 
population matched controls.  Colonic Transit times vary significantly in the population.  It varies with 
diet, time of day, coexisting medical conditions, and age. More recent studies have questioned these 
findings.  A meta-analysis of studies on addition of wheat bran did not show any increase in CTT or 
frequency of defaecation[129].   A study of colonic motility over a 24hr period in patients with DD has 
shown increased motility and propulsive force compared to health subjects[130]. A recent systematic 
review of manometry data showed significant heterogeneity and methodology, and recommended 
further high quality studies with standardized reporting using modern manometry techniques[131]. 
 
Traditionally, it was believed that patients with DD generated higher pressures during segmentation 
in their colons.  Thickened smooth muscle was observed in colonic walls of patients with DD.  It was 
thought that this caused a stronger contraction and generation of higher pressures. As discussed 
previously in page 28, it is now thought that the thickening is due to increased deposition of elastin 
and collagen rather than smooth muscle hypertrophy or hyperplasia.  Studies on colonic resting 
pressures were performed in a small number of patients, and there have been methodological flaws 
in the studies themselves.  The pressures were measured by inflating a balloon in the colon.  
Paradoxically, studies have shown that inflating balloons in the colons of patients with DD results in 
the muscle layer yielding more quickly than in healthy controls [132, 133].   Preparation of bowel for 
testing and introduction of transducers also alters resting states.  Measurements therefore may not 
be a true reflection of native pressures.  These studies were also performed for short periods of time, 
and may not be an accurate reflection of colonic pressures over a longer period of time.   
 
 The incidence of DD increases with age.   Studies of CTT in the older patients have been conflicting, 
with some studies showing a slower rate of passage [134, 135], while others showing no difference 
[136, 137]. To date, there is no conclusive evidence of reduced CTT or increased pressure in colons of 
patients with DD compared to patients without. 
 
While most motility studies show a reduction with DD, a study by Shafik et.al.  showed two different 
electrophysiological activity patterns in DD[138].  In the early stages, there was elevated 
electrophysiological activity, suggesting hypermotility.  In the later stages, there is a low or absent 
electrophysiological activity 
 
3.3.2.4 Cellular, Myenteric Nervous and Molecular Signalling Dysfunction. 
 
Strong evidence exists for neurophysiological disturbance in diverticular disease, especially in later 
stages of the disease.  Multiple studies have shown aberrant responses to stimuli in colonic smooth 
muscle of patients with DD[139-141].  Most studies show decreased response to electrophysiological 
stimuli in ex-vivo specimens of patients with DD.  Studies have described a reduction in myenteric 
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plexus in patients with diverticulosis [142, 143].   Studies have reported reduced ganglionic nerve cells 
in affected smooth muscle[143, 144]. Studies have also shown significant reduction in Glial Cell and 
Interstitial cells of Cajal, as well as reduced signalling between cells in resected sigmoid specimens 
containing diverticular disease[145, 146].   
 
Animal models show a natural decrease in enteric nerve density with ageing [140, 141].  Histological 
studies on humans have also shown decrease in enteric nerve density and ganglia with ageing [140, 
147, 148].  It has been hypothesized that with ageing, there is decrease in enteric neurons, resulting 
in impaired colonic motility, possibly resulting in DD.  Studies on this however are conflicting as other 
studies have found increased, albeit disorganized ganglia in diverticular disease [114]. 
 
There is increasing evidence that Interstitial cells of Cajal act as pacemaker cells, and maybe 
responsible for generation of slow waves[149].  Disruption of these cells could result in relative colonic 
hypomotility.   
 
The survival and maintenance of enteric neurons is dependent on neurotrophic factors, such as Glial 
Cell Line-derived Neurotrophic factor (GNDF).  GNDF is a member of the TGF-B family of growth 
factors.  Loss of the gene for GNDF leads to complete loss of enteric neurons.  In a study by Bottner 
et. al., when colons of patients with diverticulosis were compared to patients without diverticulosis, 
there was significant downregulation of mRNA of GNDF and its receptors[145].  This research, while 
still in its infancy, represents a promising new avenue for the search of pathogenesis of diverticulosis, 
and possible avenue for gene therapy in the future 
 
Figure 6 - mRNA Expression of the GDNF system in muscularis propria of the human colon 
From Bottner et.al[145] 
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This is an area of future study.   This evidence while interesting, is largely speculative because there 
remains a lack of an animal model for diverticular disease.  Neuronal issues may lead to Motility 
problems, but how this results in formation of diverticulae remains unclear.   Most studies to date 
were performed in small numbers of patients, using specimens obtained from acute operations, i.e 
complicated diverticular disease.  Some studies used colon from patients with colorectal cancer as 
control.  This may not be an accurate reflection of all patients with DD.  It is not known if 
neuromuscular dysfunction is a factor in pathogenesis in early stages of disease, or in late stages.  It is 
not known whether this occurs in asymptomatic patients.  As yet, no conclusive evidence exists to 
date of neuromuscular dysfunction in the pathogenesis of DD.  
 
3.3.2.5 Dietary Fiber and Lifestyle Factors 
 
Insufficient dietary fibre intake was thought to be the cause of DD for half a century.  In 1949 Carlson 
et.al. conducted a study on rats fed low fibre and high fat diet, and found increased incidence of 
diverticulosis[150].   Subsequently, in Painter and Burkitt’s seminal work in 1960’s, dietary fiber was 
proposed in the pathogenesis of DD[36, 37, 128, 151].  Painter observed that DD was almost unheard 
of in Africa, where fibre intake was higher.  They also observed that incidence of diverticulitis 
decreased among European migrants to Singapore, Fiji and Nigeria[37].  The proposed mechanism of 
pathogenesis was that deficiency in fibre led to passage of smaller harder stools, which required 
greater work by the colon to expel.  This raised intraluminal pressures, resulting in diverticular disease.  
Painter stated that diverticulosis, like scurvy, is a deficiency disease, and therefore, should be 
preventable[36].  Painter then performed a study adding unprocessed bran in diets of 70 patients with 
symptomatic DD, and found marked relief of symptoms in 62[151]. This lead to the recommendation 
of addition of fibre to patients with symptomatic diverticular disease, a practice that is still endorsed 
by current guidelines and recommendations of professional bodies. 
 
There are significant flaws in these studies and their conclusions.  Painter and Burkitt’s work assumed 
diet to be uniform within the African countries.  This is not true, as diet varies considerably depending 
on geographical location within the country, level of urbanisation, and socioeconomic status.  There 
has been a shift towards western diet in the latter half of the century in Africa.  
 
During the time of Painter’s studies, life expectancy in African countries was low.  This has not changed 
significantly in recent years.  The World Health Organisation (WHO) reports average life expectancy 
currently in South Africa is 52.62yrs, Nigeria is 51.86 years and in Kenya is 57.08 years.  As incidence 
of DD increases with age, one would expect countries with low average life expectancy to have lower 
prevalence anyways.  Data from the UK has also shown that while consumption of refined foods have 
increased and consumption of fibre has significantly decreased since the 1940’s, the age adjusted 
mortality from DD has not changed significantly[152]. 
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Subsequent studies to confirm the low fibre pathogenesis theory have produced limited and 
conflicting results. There is a significant paucity of good quality studies on large number of patients.  
Most studies were observational interventional studies performed on small numbers of patients.  
Larger studies have focused on symptomatic patients or patients with diverticulitis only, ignoring the 
large majority of patients with asymptomatic disease.  
 
Gear et.al. performed a study of asymptomatic diverticular disease among vegetarians and non-
vegetarians in UK[153]. They found non-vegetarians had a significantly lower intake of fibre, and 
higher incidence of diverticular disease. Confounding this is the fact that in their study, vegetarians 
with diverticulosis consumed more fibre than non-vegetarians without diverticulosis. 
 
A systematic review of the role of high dietary fibre in diverticulitis was performed by Unlu and 
colleagues in 2012[154].  They found only 3 randomised controlled studies and one case controlled 
study of sufficient quality for meta-analysis. The 3 randomised studies had inconsistent results.  Two 
showed significant improvement in symptoms although a significant placebo effect was seen in one.  
The third study showed no effect of fiber.  A similar review of clinical studies by Hume et.al. concluded 
that although fiber supplements were widely used and recommended, there was little evidence to 
support their use in uncomplicated DD, but some people may report improvement in symptoms[155].   
 
Aldoori et.al. prospectively looked at dietary fiber and risk of symptomatic diverticular disease in 
43,881 U.S. male healthcare professionals[156].  They found risk of symptomatic DD was higher in the 
quintile with lowest fiber intake. Similarly, the European Prospective Investigation into Cancer and 
Nutrition-Oxford Cohort (EPIC-Oxford) looked at 47,033 British men and women for an average of 12 
years[157].  They found that adjusted relative risk of hospitalisation with symptomatic DD for patients 
in the highest category of fiber intake was almost half that of those with the lowest intake. The main 
criticisms of these studies are that they do not look at asymptomatic DD.  These studies also included 
patients with diverticular bleeding in the category of symptomatic DD. 
 
A more recent observational study by Peery and colleagues looked at 2104 patients undergoing 
colonoscopy[158].  These patients were then interviewed and diet and lifestyle information was 
collected.  They found that DD was more prevalent in patients with high fiber diets.  They also found 
a dose response relationship, with patients with >3 diverticulae having higher fiber diets than patients 
with <3 diverticulae.  They concluded that a high fiber diet did not protect against asymptomatic 
diverticulosis.   
 
These studies suggest that addition of fiber in patients with symptomatic DD results in improvement 
in symptoms, and reduction in hospital admissions and complications of DD.  It has not been 
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conclusively shown that addition of fiber reduces incidence of asymptomatic DD. The risk factors 
transforming asymptomatic DD to acute diverticulitis and symptomatic DD are also poorly understood.  
 
Other lifestyle factors such as smoking, alcohol, and caffeine intake have been looked at. Aldoori and 
colleagues, in the largest prospective study of risks of symptomatic DD in men, looked at a cohort of 
47,678 men [159].  They found only 382 cases of acute diverticulitis (0.8%).  There was no significant 
association between alcohol intake, caffeine intake or smoking with risk of acute diverticulitis. This 
however does not look at asymptomatic diverticulosis.  
 
Physical activity has also been studied.  Physical activity may be a surrogate marker of obesity.  
Reduced physical activity has been associated with increased DD in women in Sweden [160]  Women 
who exercised more than 30 minutes a day had a 46% lower risk of diverticular bleeding and 25% 
lower risk of diverticulitis .  A small study of runners showed vigorous physical activity (running 
>8km/day) was associated with a 69% risk reduction for symptomatic DD, compared to runners who 
ran less than 2km/day[161].   
 
3.3.2.6  Medical conditions 
An increased incidence of diverticular disease has been noted in various medical conditions. As 
discussed previously, diverticulosis has been reported at a higher rate in patients with Polycystic 
kidney disease.   Epidemiological studies on these are difficult, as diseases do not occur in isolation, 
but often in combination with other factors.  Other acquired conditions that have been associated 
with DD include 
 
3.3.2.6.1 Hypothyroidism 
A large retrospective case control study of 3,175 patients in Israel showed a 2.4 times higher risk 
of diverticulosis if there was a diagnosis of hypothyroidism[162].  It is thought that hypothyroidism 
could result in colonic hypomotility and constipation, which could result in diverticular disease.   
3.3.2.6.2 Diabetes 
Studies on DD in patients with diabetes have been conflicting.  The same Israeli study as above 
showed a decrease in incidence of DD in diabetics by about half.  Another study in middle aged 
Japanese males however showed doubling of the incidence of DD in males with Diabetes[163].  
Similarly, in a Korean study, Diabetes has found to be an independent risk factor for presence of 
DD[92].  A study in Saudi Arabia also showed increased DD in Diabetics[99].  These studies were 
conducted in Asian populations, which have a different pattern of disease compared to Western 
populations.  It is not known if these results are generalizable to all diverticular disease.  
3.3.2.6.3 Hypertension 
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Studies on hypertension have also been conflicting.  Some studies have shown significantly higher 






Acute diverticulitis (AD) results from inflammation of a diverticulum.  Diverticulitis affects between 
10-25% of people with diverticulosis.  The cause is poorly understood.  Most of the people will 
experience only a single episode of diverticulitis.  A small proportion experience recurrent 
diverticulitis.  The risk factors for recurrent diverticulitis are again, very poorly understood.  
 
Clinically, diverticulitis can present in wide spectrum ranging from uncomplicated disease to abscess, 
to perforation, to fistula formation.  Uncomplicated diverticulitis is usually defined as the presence of 
colonic diverticular disease with localised wall thickening and/or stranding of pericolic fat on CT. 
Complicated diverticulitis was defined as; the presence of abscess, perforation (including any pericolic 
or extraluminal gas), obstruction or fistula formation, protracted disease with symptoms, or an 
associated mass lesion. 
 
Of all patients with AD, about a quarter present with complicated diverticulitis at first presentation.  
Not all patients with complicated disease have prior episodes of diverticulitis[164]. Previously it was 
thought that diverticulitis progressed in a linear fashion, but this is not thought to be the case now.    
Because of the variety of presentations, and lack of clear progression, these entities may have 
separate pathogenesis.  Complicated and uncomplicated diverticulitis may be separate clinical 
entities, with differing pathogenesis, natural history and outcomes.  
 
Clinically, diverticulitis is manifested by onset of abdominal pain and fever.  Blood tests usually show 
an elevated White Cell Count and neutrophilia, and an elevated C-Reactive Peptide (CRP) and 
Erythrocyte Sedimentation Rate (ESR).  Diagnosis is usually confirmed with cross sectional imaging or 
CT scan.   CT scanning also allows for radiological classification of the disease into uncomplicated and 
complicated diverticulitis. 
 
Acute diverticulitis accounts for a significant proportion of all acute surgical admissions.   Annually 
there are about 152,000 yearly hospitalisations in the US alone for diverticulitis[165].  Of all patients 
with diverticulosis, up to 25%  will developing symptomatic acute diverticulitis or complications of 
diverticular disease[166]. Hospitalisations for acute diverticulitis are also on the increase.  In Finland 
cases of complicated diverticulitis have increased 50% over the last 20 years[167] Admission rates for 
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diverticular disease have increased by up to 16% over the past decade [168].  Of all the patients 
admitted with diverticulitis, about 32% will have at least one further admission within 1 year.   
 
4.2 Pathogenesis of Diverticulitis 
The underlying pathological mechanism that leads to diverticulitis remains unclear.  Rather than a 
single causative factor, it is likely that a number of factors are involved in an as yet poorly understood 
mechanism.  Historically, it was thought that diverticulitis occurred as a staged progression of DD, 
starting with development of diverticula, and progressing to pericolitis, phlegmon formation, abscess 
and eventual perforation.  This has now been disproven.  The cause is likely to be due to complex 
interactions involving environmental and genetic factors.  Some of the implicated factors in 
pathogenesis are discussed below 
 
4.2.1 Stasis, Obstruction and Inflammation 
 
Similar to the theory of pathogenesis of appendicitis, this theory hypothesizes that the pathogenesis 
is diverticulitis is the result of faecal matter causing obstruction of a diverticulum[169].   A faecolith or 
hard inspissated faeces obstructs the narrow neck of a diverticulum.  This results in a low grade 
inflammation from the continuous abrasion of the mucosa from hard faeces.  Loss of mucosal barrier 
allows for translocation of colonic microbiota into the lamina propria, leading to inflammation of the 
mucosa[170, 171].  A second theory is that inspissated faeces in diverticula leads to obstruction, which 
then leads to bacterial overgrown in an anaerobic environment, and local tissue ischemia from 
increased pressure.   
 
There are several flaws with these theories.  Cultures of peritoneal fluid for perforated diverticular 
disease most commonly show mixed anaerobic and aerobic organisms[172]. This goes against 
obstruction and overgrowth in an anaerobic environment.  Diverticulitis can also occur in the presence 
of large mouthed diverticulae, which do not obstruct.  On cross sectional imaging and at histology, 
rarely are obstructing faecoliths found in diverticulae.   
 
Progression of acute diverticulitis to complicated disease, including  perforation and fistulation occurs 
in only a small proportion of patients.  This goes against a constant irritation or obstruction theory. 
 
It has been noted that mucosal inflammation can coexist with diverticular disease[173-175].  This so 
called “Segmental Colitis” or “Diverticular Colitis” has similar features histologically to inflammatory 
bowel disease. It has been known that a proportion of patient continue to have symptoms long after 
signs and symptoms of inflammation have abated.  Segmental colitis has been proposed to be the 
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causative agent for their symptoms.  Chronic low grade inflammation can also result in altered 
neurophysiology which can alter colonic motility.  
 
4.2.2 Dietary Fiber Hypothesis 
 
Dietary fiber has been implicated in pathogenesis of diverticulitis.  A high fiber diet has experimentally 
been shown to alter colonic flora and micro-ecology of the colon of patients [176, 177].  This may 
result in a change in the immune response of the patient.  Addition of probiotics to diet has been 
shown to modulate intestinal immune response, which may result in down regulation of intestinal 
inflammatory responses [178, 179].  A theoretical progression to diverticulitis from low fiber diet is 
shown below.   
 




This model postulates that a microperforation in a diverticulum leads to an inflammatory response, 
which then progresses onto diverticulitis and its complications.  Several potential causes for this 
microperforation have been proposed.  Stasis and obstruction as mentioned earlier can lead to 
microperforation.  The neck is usually the narrowest point of the diverticulum.  This passes through 
the muscle layers, and can be compressed by contraction of the muscle.  This can result in increased 
pressure on the head of the diverticulum, possibly resulting in microperforation.  It can also result in 












4.3 Risk Factors for Diverticulitis 
 
4.3.1 Age and Sex 
The incidence of diverticular disease increases with age, and as expected, the incidence of 
diverticulitis also increases with increasing prevalence. There is clearly an association with age and 
diverticulitis.  Traditionally, diverticulitis was thought of as a disease of the elderly [180]. Recently 
however, there has been an increasing incidence of AD in younger populations.  In a large review 
of admissions between 1998 to 2005 in the US population, the average age for AD decreased from 
64.6 to 61.8 during the study period [181].  Incidence rates remained stable in the 65-74yo age 
group, but increased dramatically in the 18-44yo and 45-64yo age groups. 
 
Sex differences have also been noted, but studies are conflicting.  Early studies suggested a higher 
incidence in males [182].  Schauer and colleagues reported double incidence of diverticulitis in 
males compared to females in less than 40yo, and 1.5 times increased incidence in greater than 
40yo[103].  More recent data from UK and Canada however have showed a higher incidence of 
hospitalisation in women compared to men [168, 181].  
 
4.3.1.1 Younger Patients 
 
Diverticulitis is relatively rare before the age of 40.  Patients less than 40 yo account for only 2-5% 
of all patients with acute diverticulitis [102, 183].  There is evidence that the incidence of acute 
diverticulitis in this subgroup is increasing.  Recent epidemiological studies have reported 
increased hospitalisations in these patients [1, 184].  Patients less than 50 account for the greatest 
relative increase in hospitalisations for diverticulitis 
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Figure 8 - Relative increase in hospitalization rates for diverticulitis in the US between 1998 and 2005, compared to 
reference year (1998) stratified by age group 
 From Nguyen et. al [184] 
 
4.3.2 Medical Conditions 
 
4.3.2.1 Hypertension 
Hypertension has been associated with an increased risk of acute diverticulitis as well as 
complicated diverticulitis.  A large prospective Swedish study by Rosemar and colleagues sowed 
an almost double risk of complicated diverticulitis in men with BP >146mmHg [185].  Diastolic 
pressure >102mmHg was also associated with a 2.2 times higher risk in the same study.   
4.3.2.2 Renal Disease 
 
Diverticular disease has been associated with polycystic kidney disease.  Multiple studies have 
looked at diverticular disease in patients with chronic renal failure[186, 187].  While studies 
suggest mild to modest increase in risk of diverticular disease, the impact on diverticulitis is less 
clear. In the absence of polycystic disease, the risk of acute diverticulitis is not increased in renal 
failure[188].  A retrospective UK study on risk factors for death with perforated diverticulitis 
however showed increased odds (OR 18.7) for pre-existing renal disease[47]. 
 
4.3.3 Immunosuppression, Steroids and NSAIDS 
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Immunocompromised patients represent an “at risk” group of patients.  These include patients 
with Acquired Immunodeficiency states, including AIDS, Immune suppressed patients such as solid 
organ transplant recipients and well as patients on chronic immunomodulatory drugs such as 
corticosteroids and anti-rheumatoid medications.   This group has been studied extensively, as it 
was thought that these patients would have a more virulent form of diverticulitis and be more 
likely to have complications related to the disease.    
 
Early case reports from 1971 from Washington University hospital reported a higher incidence of 
perforated diverticulitis among patients on chronic corticosteroids[189].  This trend was 
confirmed in multiple subsequent studies[190-193].  Prior to cross sectional imaging, the diagnosis 
was often based on clinical or operative findings, and therefore incidence of perforated disease 
was overestimated to an extent.  Later studies combined accurate diagnosis with large numbers 
to analyse trends in patients on chronic corticosteroids. Humes et.al. performed a case-control 
analysis of 899 cases of perforated diverticular disease[194].  They found that 20% of patients with 
perforation had used oral corticosteroids, compared to 10% of controls.  Overall, corticosteroid 
use was associated with a 70% increased risk of perforation.  They also looked at NSAID use, and 
found a small, non-statistically significant increase in risk of perforation. 
 
Studies on organ transplant recipients have largely been on small number of patients.  These have 
however shown a very high mortality rate with colonic perforation in these patients.  A summary 
of the studies is given below.  The most well studied group are patients with renal transplants.   
 
Table 2 - Summary of studies of mortality with colonic perforation in patients with solid organ transplants. 
Study Year Organ 
Transplanted 
Patients with Perforation Mortality 
Dalla Valle[195] 2005 Kidney 8 1 (12.5%) 
Church[196] 1986 Kidney 11 7 (63%) 
Koneru[197] 1990 Kidney 11 4 (36%) 
Squiers[198] 1991 Kidney 12 4 (33%) 
Bardaxoglou[199] 1993 Kidney 6 4 (66%) 
Benoit[200] 1993 Kidney 5 3 (60%) 
Stelzner[201] 1996 Kidney 30 11 (38%) 
Pirenne[202] 1997 Kidney 8 2 (25%) 
Lederman[203] 1998 Kidney 13 1 (7.7%) 
Catena[204] 2008 Kidney 15 7(46.7%) 
Qasabian[205] 2004 Heart/Lung 8 1(12.5%) 
     




The risk of progression to diverticulitis and perforation among these patients is low.  Hwang and 
colleagues performed a Meta-analysis of diverticulitis in transplant patients and patients on 
chronic corticosteroids. They report an overall incidence of progression to diverticulitis with or 
without perforation of 1% over a variable length of time.  In patients with known DD, 
approximately 16% progressed to diverticulitis.  Contrary to wide held beliefs, abdominal signs 
and symptoms in these patients were not masked due to immunosuppression.  Hwang reported 
an overall mortality of 23% for an emergency colectomy and a mortality of 56% for patients not 
undergoing surgery[190].   
 
Patients on NSAIDS and other Cyclo-oxygenase inhibitors represent a special category within these 
patients.  These drugs have well known effects on suppression of metabolites of Arachidonic acid, 
and the subsequent suppression of host protective mechanisms and inflammatory responses. 
Well known complications of these drugs include gastrointestinal tract ulceration and reduction 
of adhesiveness of platelets, resulting in increased risk of bleeding.  Small cohort studies have 
shown an increased risk of perforation among patients on regular NSAIDS[192, 206, 207].  A large 
study of 939 patients by Strate and colleagues found an increased risk of diverticular bleeding as 
well as diverticulitis with regular use of Aspirin and NSAIDS [208]. 
 
4.3.4 Geographical and Seasonal Factors 
Seasonal variations and cyclical patterns have been observed in hospitalisations for AD in USA.  
Ricciardi and colleagues reported an increase in hospitalizations in summer months by about 
25%[209].  This was noted to be independent of region, age, sex and race.  Nguyen and colleague 
noted regional variations in USA, with highest incident for hospitalization for AD in North-eastern 
states, and lowest in the Western and Midwestern states[184].  Risk for hospitalization has been 
risked to sunlight exposure and Vitamin D levels.  Higher Vitamin D levels have been associated 
with significantly lower risk of diverticulitis[210]. 
 
4.3.5 Diet and Lifestyle Factors 
 
As previously the link between diet and DD is weak at best. Evidence for the role of fiber in 
Diverticulitis is marginally stronger.  There have been at least 3 large epidemiological studies 
addressing this issue. 
 
The Health Professional Follow-up Study (HPFS) of 48,000 men showed that men with the highest 
intake of fiber (>32g/day)  had the lowest risk of symptomatic diverticulitis, with an estimated risk 
reduction of 42% compared to those with lowest fiber intake[211].  Similarly, the European 
Prospective Investigation into Cancer and Nutrition (EPIC) study of 47,033 men and women from 
Scotland and England showed a 41% lower risk of hospitalisation in participants with the highest 
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(>25g/day) intake of fiber [157]. Vegetarians also had lower risk. The Million Women Study of 
690,075 middle aged women also showed reduced risk of admission and death in women with 
highest (>17.6g/day) Fiber intake[212].  In this study, the effect was noted to be different 
depending on fiber consumed, with strongest effect seen in cereal and fruit fiber. 
 
The main criticism of these large epidemiological studies is that hospital admission does not 
always equate to acute diverticulitis.  These studies were conducted prior to the routine use of CT 
scanning to prove acute diverticulitis.  It is difficult to know whether the symptoms and observed 
risk reduction represent Acute Diverticulitis, Symptomatic Diverticular Disease, Diverticular 
Complications or functional bowel problems associated with DD.  
 
Other dietary factors that have been studied includ Dietary Fat[93, 211], Red Meat[211], Dairy 
Products[213], Caffeine[159], Micronutrients (Potassium, beta carotene, Vitamin C and 
Magnesium)[211], and Nuts, corn and popcorn[214].  None of these have been associated with 
any significant increase in Acute Diverticulitis. 
 
Lifestyle factors studied have included Alcohol Intake and Smoking.  In the prospective HPFS study, 
there was a modest increase in risk (RR 1.38) of symptomatic diverticular disease in men with 
alcohol consumption greater than 30g/day[159].  In the EPIC study however, significance of the 
effect of alcohol disappeared after adjustment for smoking. In a study by Papagrigoriadis, there 
was no difference in alcohol consumption in patients with and without complicated 
diverticulitis[215].  
 
Smoking has long been known to have a negative effect on the immune system and increase the 
risk of infectious complications.  Hjern and colleagues, in a study of 36,000 Swedish women, found 
a 24% increased risk of hospitalization for DD in smokers, even after controlling for age, fibre, 
medical comorbidities, Medications, BMI and physical activity[160].  There was no clear link with 





Diabetes is reaching almost epidemic proportions in western countries.  Diabetes has well 
recognised effects on the immune system, with increased risk of infections[216, 217]. 
 
Diabetes may increase risk of acute diverticulitis by increasing risk of infection.  A study by Cologne 
et.al. of 1019 patients with diverticulitis showed a higher Hinchey score in diabetics vs non 
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diabetics[218].  Despite this, the success rate of non-operative management was similar in both 
groups.  This suggests that diabetics may be at risk of having more advanced disease.  This remains 
a very poorly studied area, and is an area for study in this project. 
 
4.3.7 Physical Activity and Obesity 
 
Anecdotally, surgeons have noted that patients undergoing emergency operations for 
diverticulitis and its complications have higher BMI’s than the general population.    There is a 
paucity of studies on obesity and diverticulitis.  Current epidemiological trends show a worrying 
increase in obesity in western countries.  In the USA, the Centre for Disease Control estimates 36.5 
% of all adults to be obese[219]  
 Smaller studies have suggested an increased risk of complicated diverticulitis in obese patients 
[103, 220, 221].   Jeong and colleagues looked at visceral fat in patients with diverticulitis in 130 
patients.  They found that patients with higher visceral fat were significantly more likely to have 
complicated disease [221].  Dobbins and colleagues performed a retrospective study that looked 
at mean BMI among 61 patient, of whom 16 underwent an emergency colectomy[220].  They 
found that patients with higher BMI’s had significantly higher risk of perforation and abscess 
formation, as well as recurrent diverticulitis.  
Two large prospective studies have looked at obesity and diverticular disease.  Rosemar and 
colleagues studied 7,500 men in Sweden over 28 years[185].  They found men with a BMI>30 had 
4 times the risk of diverticulitis compared to men with a normal BMI, after adjusting for age, 
smoking and blood pressure.  Similarly, Strate and colleagues looking at the 18 year follow-up data 
of the HPFS found that a BMI>30 was associated with a 79% greater risk of diverticulitis [222]. 
 
Aldoori first studied the link between physical activity and risk of symptomatic DD.  Using the HPFS 
data, a 4yr follow-up found that physical activity was inversely related to symptomatic diverticular 
disease[223].  They found sedentary activity had increased risk of symptomatic DD (RR1.32), while 
vigorous physical activity decreased risk (RR 0.6).  A further 18 year follow-up of the HPFS data by 
Strate and colleagues was published in 2009 [224].  They found that risk of complications from DD 
was associated with lower physical activity, and this effect was greatest in men with a BMI>30 
kg/m2.  Obese men with low physical activity levels had a relative risk of 1.62 for diverticulitis, and 
2.81 for bleeding from DD.  Vigorous activity was associated with a 25% risk reduction of 
diverticulitis.  
 
Although a higher BMI has been correlated with diverticulitis, the mechanism for this is less clear. 
Fat has well studied endocrine functions.  There is significant crossover between endocrine and 
immune function.  One of the best studied is Leptin.  Leptin is a cytokine released by adipocytes 
that has effects on the thalamus resulting in regulation of satiety.  Leptin also has effects on the 
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Immune system, with regulation of T cell proliferation and differentiation[225].  Abdominal fat 
has been associated with chronic diseases such as Type 2 Diabetes and Heart Disease, and is a 
central feature of the Metabolic Syndrome (Syndrome X) [226]. The immunomodulatory effects 
of uncontrolled Type 2 Diabetes are also well known.   
 
Surgeons have known of the role of the omentum in adhering to inflamed tissue, such as 
perforated viscera. Similarly in Crohn’s disease, fat wrapping around the affected segment has 
also long been noted by surgeons, and used to delineate extent of disease[227].  Surgeons have 
also known for a long time that obese patients were more likely to get infectious complications 
after major surgery, including wound complications[228].  While usually attributed to the 
relatively ischaemic nature of fatty tissue, excessive fat probably has a role in down regulating 
immune response, making infections more likely Fat cells express a range of receptors that 
mediate inflammation, including Toll Like Receptors (TLR) and Nucleotide Oligomerization 
Domains (NOD[229]).   Visceral fat has been associated with degree of inflammation in Crohn’s 
disease.  Precursors to Adipocytes in mice demonstrate phagocytic activity similar to 
Macrophages.   
 
Fat probably has a greater role in the triggering and maintenance of inflammatory states than 
currently appreciated.  All this could predispose obese patients to development of Acute 
Diverticulitis and for maintenance of symptomatic disease.  
 
5. Natural History and Recurrence of Diverticulitis 
 
The natural history of diverticulitis remains unclear. There is a paucity of literature on the long term 
follow-up and recurrence. The literature on diverticulitis is also conflicting.  Prior to routine cross 
sectional imaging, diverticulitis was diagnosed clinically.  Up to 34% of clinical diagnosis of diverticulitis 
change with cross sectional imaging [230].  Therefore studies on natural history of diverticulitis prior 
to accurate diagnoses with CT scanning have been plagued with methodological flaws.  There is a lack 
of uniformity in definitions, terminology and outcomes in studies, making comparison even more 
difficulty.  
 
Parks performed the first study on the natural history of DD. He looked at 521 patients admitted to a 
single centre for symptomatic diverticular disease. Although they do not specify what constitutes 
“medical management”, they found that the risk of hospital admissions increased significantly after 
the third admission for patients who were medically managed.  They did not follow-up any of the 




Traditionally surgery was the mainstay of treatment, and a large portion of the literature is dedicated 
to follow-up of patients after surgery.  A long term benefit from resection, electively or in an 
emergency has not yet been shown.  Over the past 2 decades, there has been an increasing trend 
towards conservative management.  This has been shown to be safe in the long term[231].  It was also 
thought that conservative management was more likely to result in complicated disease, more likely 
to require a colostomy and have increased morbidity and mortality with poorer outcomes.  This has 
also been shown to not be the case [164, 232]. 
 
The reported recurrence rate of diverticulitis varies in the literature.  The largest study performed on 
25,058 patients followed up for 14 years reported a recurrence rate of 19%[233].  Only 3.8% of 
patients had more than 1 admission.  Quoted recurrence rates in the literature after an episode of 
diverticulitis range in literature from 7% to 62% [42, 231, 234-240].  In series without imaging based 
inclusion criteria, recurrence rates have been quoted from 13-47%.  Studies with stricter imaging 
based criteria for acute diverticulitis have shown a lower recurrence rate than previously thought. A 





Table 3 - Studies after 2010 of Recurrent Diverticulitis 
Study Year Country No of 
Patients 
Design Length of 
Followup 
Recurrence 
Lahat[241] 2013 Israel 261 Prospective 88 mo 21.5% 
Buchs[231] 2013 Switzerland 280 Prospective 24 mo 16.4% 
Binda[237] 2012 Italy 743 Retrospective 10.7yr 17.2% 
Hall[238] 2011 USA 672 Retrospective 42.8mo 36% 
Makela[239] 2010 Finland 977 Retrospective - 42% 
Eglinton[240] 2010 NZ 320 Retrospective 101mo 18.8% 
       
 
The evidence suggests that recurrence after an episode of uncomplicated diverticulitis is uncommon, 
and recurrent disease is not more severe or more likely to require surgery [238, 240]. 
 
5.1 Risk factors for Recurrence of Diverticulitis 
 
Recurrent diverticulitis is uncommon. Only 10-25% of patients with DD develop acute diverticulitis.  Of 
the patients with acute diverticulitis, only 10-25% develop recurrent diverticulitis.   Studies looking at 
recurrent diverticulitis in these patients have been plagued with the same methodological flaws as 
with most studies on diverticulitis prior to accurate diagnosis with Cross sectional CT scanning.  Prior 
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to the widespread use of routine CT scanning, the diagnosis of diverticulitis was based on clinical 
findings alone.  The accuracy of clinical diagnosis is low, and previous studies have overestimated 
incidence of recurrence. There are very few studies looking at recurrence with objective CT proven 
diagnosis.  
 
It was initially believed that recurrent diverticulitis had a more virulent and severe course. Studies 
showed increased risk of perforation in recurrent disease.  It was also believed that medical 
management of diverticulitis was not likely to be successful after the second episode.  Based on these, 
recommendations were made for surgery after 2 confirmed episodes of diverticulitis.  These 
recommendations were based on historically flawed studies.  This recommendation persisted until 
the early 2000’s.   
 
More recent studies have contradicted these historical findings.  In a large cohort study of 25,058 
patients with acute diverticulitis by Anaya and colleagues, patients with recurrent hospitalization for 
diverticulitis did not have a significantly higher risk of emergency surgery or disease associated 
mortality [233].  Other studies have confirmed these findings.  It is now believed that recurrent 
diverticulitis does not carry a worse outcome that the initial episode.   Some of the factors studied are 
discussed below. 
 
5.1.1 Young Patients 
 
There has been conflicting evidence about the incidence and natural history of diverticulitis in these 
patients.  Earlier studies reported an incidence of diverticulitis between 2-7% in these patients [242-
244].  Later studies report an incidence between 18-34% [245, 246].  It was also reported in earlier 
studies that these patients had a more severe course, and had a higher rate of recurrence, more visits 
to the emergency department as well as more complications from diverticulitis when managed 
medically[102, 103, 247, 248].  This led to the advocating by some authorities of performing resection 
surgery after a single episode in these patients [249, 250]. 
 
More recently, good quality studies with relatively long term follow-up have disproven this belief. 
Recent studies have not found a significant difference in rate of conservative management, need for 
emergency surgery or risk of recurrent disease [245, 251-253].  More current guidelines recommend 
that they should be treated no differently to older patients[254]. 
 
Younger patients have a longer life expectancy, and therefore would be expected to have more 
medical contact, and higher accumulated risk, rather than absolute risk.  In the large study of 25,058 
patients followed over 14 years, patients less than 50 were more likely to have recurrence than older 
 47 
patients (27% vs 17%), were more likely to undergo emergency colectomy (RR 2.2) and were more 
likely to require a colostomy[233].  
 
5.1.2 Extent of Surgical Resection and Level of Anastomosis 
 
It has been known that a proportion of patients get recurrent diverticulitis even after surgery. As early 
as 1962, Leigh and colleagues reported recurrent diverticulitis in 72 patients from the Mayo clinic after 
apparently having undergone an adequate segmental resection for acute diverticulitis[255].   In 
another later study from Mayo clinic, Benn and colleagues reported a recurrence rate of 10.4% in 501 
patients[256]. Interestingly, they showed that 71% of the patients had persistent diverticulae in 
barium enemas after a seemingly adequate resection. They found that a rectal anastomosis was 
associated with a lower rate of recurrence than a sigmoid anastomosis.   
 
Other studies have not found an association with extent of resection and risk of recurrent disease 
[257, 258]. It was also believed initially that operating after recurrent attacks of diverticulitis may 
result in higher morbidity and mortality, due to advanced disease state, less pliable colonic wall, and 
increased age of the patient.  In mathematical modelling however, it was showed that morbidity and 
mortality were not significantly different after the 4th episode of diverticulitis than the second episode 




Buchs and colleagues looked at patterns of recurrence after an episode of uncomplicated diverticulitis 
[231].  Of the 280 patients included in their study, the overall recurrence rate was 16.4%, with more 
than half the recurrences in the first year.  Of the patients with recurrent disease, only 2.1% were 
complicated and only 1.4% required an emergency colectomy.  On univariate analysis, they found that 
the CRP on admission was strongly correlated with recurrence within the first six months.   The cut-
off value for CRP was about 240mg/l.  The graph below shows probability of recurrence vs time to 
recurrence based on CRP. 
 48 
Figure 9 - Effect of CRP on Recurrence 
Buchs et.al. 2013[231] 
 
5.1.4 Smoking and Lifestyle Factors 
 
Smoking has well described effects on the immune system.  Smokers have a vastly higher risk of 
infectious diseases, including respiratory infections, wound infections etc. [261].  Smoking has 
been directly correlated with increased risk of recurrence of autoimmune diseases such as Crohns 
disease [262].  While epidemiological studies have shown increased risk, the mechanism of this is 
less clear.  Proposed mechanisms include immune dysregulation via toxins in tobacco smoke, 
structural changes in cilia and mucosa from smoking, and increased bacterial virulence in smokers. 
 
Epidemiological studies on smoking and diverticular disease are conflicting.  Two studies have 
associated smoking with increased risk of complicated diverticular disease [215, 263].  A larger 
epidemiological study, however, did not show increased disk of diverticular disease [159]. 
 
Similarly other lifestyle factors have been studied with mixed results.  Physical activity and obesity 
have been addressed above.  Other factors studied have included caffeine use, Nuts, Corn and 
Seed consumption, Red Meat consumption and alcohol use[264].  None of these factors have been 
shown to conclusively increase the risk of either diverticulosis or diverticulitis.  There has been a 
weak association with increased risk of alcohol with diverticulosis, although it it is hard to draw 
definitive conclusions given significant heterogeneity in the studied patients [159].  After 
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adjustment for smoking, the relationship between alcohol and diverticular disease was no longer 
significant in one study [157].  
 
5.1.5 NSAIDS, Steroid Use and Autoimmune diseases 
 
Non-steroidal anti-inflammatory medications (NSAID’s) are amongst the commonest over the 
counter medications in use today.  Up to 26% of the US population using an NSAID regularly[265].  
Oral corticosteroids are also widely used for a variety of conditions.  Both these medications have 
well recognised effects on the immune system.  NSAIDS have long been associated with loss of 
mucosal barrier and peptic ulceration due to inhibition of prostaglandin synthesis and the 
subsequent loss of the gastric mucosal barrier.   
 
The role of both these drugs in Diverticular disease and diverticulitis has been studied.  Regular 
NSAIDS have been associated with and increased risk of diverticular bleeding and diverticulitis 
[208, 266].  They have also been associated with an increased risk of complicated diverticulitis 
[267-269].  The mechanism for this, again, remains unclear.  
 
Patients on oral corticosteroids have also been shown to have a higher risk of acute diverticulitis 
and complicated diverticulitis [194, 270].  This seems more so in immunosuppressed patients.  
Organ transplant patients on oral steroids have been shown to have a higher risk of diverticulitis, 
and higher mortality[190].  Patients with rheumatoid arthritis have also been shown to have a 
higher risk of complicated DD while on oral steroids [193]. 
 
Most of these studies have been epidemiological, and most looked at acute presentations of 
diverticulitis.  There is significant paucity of literature on what effect these medications have on 
Recurrence of diverticulitis.   
 
 
5.1.6 Family History and Genetics 
 
While a genetic component of diverticular disease has not been shown, it has been recognised for 
a while that there may be a familial association.  In 1926, Mackoy reported a familial group with 
long standing abdominal symptoms and diverticular disease on X-ray examinations of the bowel 
[271].  There is some evidence of a genetic component.  An interesting study of the Swedish Twin 
Registry showed that the Odds Ratio of developing diverticular disease was 7.15 times higher if 
the co-twin was affected[272].  This correlation was higher in monozygotic than dizygotic twins. 
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The influence of a family history on the risk of recurrence has been studied.  Hall et al. looked at 
954 patients with diverticulitis had found that a family history of diverticulitis was associated with 
a higher risk of recurrence [238].   Further studies are needed to confirm this finding. 
 
6. Summary and Conclusions 
 
Despite significant advances in medical knowledge, diverticular disease remains an enigma.  The 
history of diverticular disease has been plagued with flawed conclusions and inferences, leading to 
treatments which may not have been in the patient’s best interests.  Historically flawed data has led 
to unclear and conflicting evidence on the pathogenesis of diverticular disease and diverticulitis.  This 
has then resulted in flawed practice recommendations, which could result in harm to the patient.  This 
has been demonstrated in the practice of performing resection after 2 confirmed episodes of 
diverticulitis. 
 
Rapid advances in medical technology, especially in radiological imaging has resulted in greater 
accuracy in diagnoses, and allowed for management options which were not previously available.   
 
Despite all this, basic questions remain unanswered about diverticular disease.  The aim of this project 
is to look at risk factors for diverticulitis and recurrent diverticulitis.  The main factors looked at are 
the least understood risk factors and risk factors that have conflicting literature.  These include the 
influence of obesity, the influence of NSAIDS and oral corticosteroid medications, influence of 
autoimmune diseases and the influence of diabetes.  Chapter 2 addresses the influence of these risk 
factors in acute diverticulitis, and chapter 4 addresses the influence of these on recurrent diverticulitis 
 
We also wish to examine areas of practice in the management of acute diverticulitis that may have 
stemmed from historical beliefs, which may not be relevant in the modern setting.  Historically, 
diverticulitis was largely a clinical diagnosis.  Clinical diagnosis is subject to error, and up to 40% of 
diagnoses change with Cross sectional imaging of the abdomen [230].   Colonoscopy has been 
recommended by practice guidelines after an episode of diverticulitis.  This practice may, however, 
stem from historical inaccuracies in diagnosis.  The role of colonoscopy in a modern setting with cross 
sectional imaging proven diverticulitis is not known, and is also an area of study for this project.   This 
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Colonic diverticulae are very common in older adults though usually asymptomatic.  The reason why 
some develops diverticulitis while others do not is uncertain.   Studies have suggested an increased 
risk of diverticulitis in the obese. Other studies have suggested an association between Non-Steroidal 
Anti-Inflammatory Drugs (NSAIDs), corticosteroids and immunosuppressants with complicated 
diverticular disease.    The aim of this study was to study effect of some chronic illnesses and these 
drugs on incidence of patients presenting with acute diverticulitis. 
 
Methods 
All patients admitted with a diagnosis of acute diverticulitis (AD) from January 1998 to Dec 2010 at 
Christchurch Public Hospital were included.  Medical records were analysed for concurrent chronic 
illnesses, regular use of immunomodulatory drugs, management and follow-up.  Using computerised 
tomography of the abdomen (CT) data, estimation was made of Body Mass Index (BMI) and weight.  
 
Results 
There were 1299 patients, 582 male and 716 female, median age 64, range (18-98).  Of all patients, 
79.6% had a BMI >25, and 55.2% of patients having BMI >30.  Patients with diabetes were significantly 
more likely to have uncomplicated diverticulitis (54.2% vs 41.3%). BMI, weight, use of regular NSAIDS, 
steroids and immunosuppressants did not have a significant effect on nature of disease (complicated 
vs. uncomplicated) at presentation nor were they significant predictors for need for intervention. 
Recurrent diverticulitis will be addressed in Chapter IV. 
Conclusion 
Obesity is common in patients with diverticulitis and may be associated with an increased risk.  
Diabetes, Autoimmune diseases, NSAIDS, Steroids and Immunomodulatory drugs do not affect stage 





Acute Diverticulitis (AD) represents a spectrum of disease, ranging from simple uncomplicated 
diverticulitis to perforated disease with generalised peritonitis.  It is a significant problem, and in 2004 
accounted for 312,000 admissions and 1.5 million days of inpatient care in the US alone[273].  Up to 
60% of all people in industrialised countries will develop colonic diverticular in their lifetime, and of 
these, up to 25% will develop an episode of acute diverticulitis or its complications[274].  Admissions 
for acute diverticulitis have increased by up to 16% in the past decade[165, 168].  The rates of 
admission have increased in young patients.  In the united states alone, admissions for patients less 
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than 44 yo increased by 82% between 1998 and 2005[273].  The incidence of complicated diverticulitis 
is also increasing, with a reported 50% increase in Finland over the last 20 years[167, 239]. 
 
There has been a considerable shift towards conservative management of this disease over the past 
2 decades[275].  Despite the prevalence of this disease, the natural history is poorly understood.  Why 
some patients get diverticulitis and others do not is not clear.   The risk factors for getting acute 
diverticulitis are also poorly understood.  Identification of risk factors for diverticulitis could potentially 
lead to better identification of patients likely to benefit from intervention.  
 
Previous studies have shown an association between use of Non-Steroidal Anti-Inflammatory Drugs 
(NSAIDs) and complicated diverticular disease[268].  Aspirin (also an NSAID) has been associated with 
increased risk of diverticulitis and diverticular bleeding[208].  Corticosteroids and oral opiates have 
been associated with increased risk of perforated diverticular disease[194].   
 
Obesity is also a risk factor of interest in studies of diverticulitis.  Anecdotally, surgeons have noted 
patients undergoing emergency operations for diverticulitis to have higher BMI’s than the general 
population.  In 1869, Klebs in writing the Handbook of Pathological Anatomy noted Diverticular 
disease was commoner in obese patients[15].  Todd, in the Hunterian Lecture at Royal College of 
Surgeons in 1955 noted “Almost all the patients are fat”[41].   
 
Studies have shown an increased risk of complicated diverticulitis in obese patients[103, 220, 221, 
228].  In patients requiring emergency colectomy, higher BMI’s have been associated with higher risk 
of perforation and abscess formation, as well as increased post-operative morbidity and costs[220, 
276].   Increased physical activity has been associated with a lower risk of complications of diverticular 
disease[224].  Clearly obesity has a role in the course of AD, but the exact mechanism remains elusive.    
 
Obesity is directly linked to insulin resistance and diabetes[277].  Diabetes has known effects on the 
immune system, resulting in an increased risk of infection[278].  Diabetes impairs phagocytic function 
of macrophages as well as T cells [217, 278, 279].  Chronic autoimmune diseases also impair immune 
responses, resulting in increased risk of infections [235].  The effect of these diseases on the risk of AD 
is unknown.  Impaired immune responses could result in increased susceptibility to diverticulitis.   
 
The purpose of this study was to assess the effects of chronic illnesses including diabetes, autoimmune 
diseases, weight and BMI, as well as the regular use of NSAIDs, corticosteroids and 





 A retrospective audit was performed of all patients admitted with a diagnosis of colonic diverticulitis 
and its complications at Christchurch Public Hospital.  Christchurch Hospital is the largest tertiary 
centre and teaching hospital in South Island of New Zealand.  It serves a wider population of about 
566,000, and has about 8400 general surgical admissions annually. 
 
Patients were identified from hospital discharge summary coding information.  A search was 
performed of all patients admitted with a diagnosis code including diverticular disease of the colon 
from January 1998 to December 2010.  Medical records were analysed to 2013, to allow a minimum 
of 3 years of follow-up after diagnosis.  There was no restriction on age, sex or location of diverticulitis 
within the colon.  Patients were excluded if the diagnosis was other than acute colonic diverticulitis, 
including small bowel diverticula.   
 
The inpatient notes and discharge summaries of all potential patients were then analysed.  A database 
was created.   Demographic data collected included age and sex of patient. The date and method of 
first diagnosis was recorded (e.g. clinical diagnosis, CT scan, colonoscopy, surgery etc.).  If cross 
sectional imaging was used in the initial diagnosis or if the patient underwent surgery, the location of 
diverticulitis was recorded.  
 
If cross sectional imaging was performed, patients were then further divided into uncomplicated and 
complicated disease.  Uncomplicated diverticulitis was defined as the presence of colonic diverticular 
disease with localised wall thickening and/or stranding of pericolic fat on CT. Complicated diverticulitis 
was defined as; the presence of abscess, perforation (including any pericolic or extraluminal gas), 
obstruction or fistula formation,  or an associated mass lesion. The nature of disease was also 
recorded.    
 
The drug charts and medical notes were then analysed for regular use of NSAID’s (including low dose 
aspirin), oral corticosteroids, and immunosuppressive medications.   The dose of the drugs used was 
also recorded. The use of aspirin was divided into Low Dose (75 – 150mg once daily) and Regular Dose 
(500mg - 1g).  The use of prednisone was divided into Low and High Dose.  Low dose was defined as a 
combined daily dose less than 10mg per day, and high dose was defined as greater than 10mg per 
day.  Medications were only recorded if they were used continuously.  Intermittent or sporadic use of 
medications was not recorded.   The presence or treatment of concurrent Diabetes and Autoimmune 
diseases were also recorded.   
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The management of diverticulitis at index admission, and recurrent admissions was recorded. If the 
patient underwent a surgical or interventional radiological procedure at any time from the diagnosis 
to completion of study, this was recorded. Data recorded included type of procedure, time from initial 
diagnosis to procedure, subsequent procedures (e.g. reversal of Hartmann’s. 
 
Using a validated tool, If cross sectional imaging was used in the diagnosis of diverticulitis, the body 
mass index (BMI) of the patient was calculated[280].  The following metrics were collected.  All 
measurements were performed at the L1 lumbar vertebrae (Transpyloric plane). 
- Circumference of body (BC) 
- Total body area (Ba) 
- Intra-abdominal area (IAa) - Circumference between abdominal musculature and outer fatty 
parameter 
- Ratio of subcutaneous fat to total body area SQa (=Ba-IAa) 
- Antero posterior body diameter (BAPD) 
- Transverse body diameter (BTD) 
- Spinal Canal Area (SCA) 
- Transverse Diameter of L1 (L1a) 
- Antero posterior diameter of L1 (L1APD) 
- Area of L1 (L1A) 
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 Geraghty et al.[280] 
Using these anthropometric parameters, determinations were made of height, weight, Body Mass 
Index (BMI) and Body Surface Area (BSA) as outlined by Geraghty et.al.[280].  In their validation study, 
comparisons of calculated values were statistically indistinguishable from actual measured values.   
 
Data on colonic evaluation after initial diagnosis, including colonoscopy, barium enema etc were also 
recorded. If diverticulosis was reported at colonic evaluation, the site of diverticulosis was recorded.  
A finding of colonic malignancy at any time after diagnosis was also noted. Data was also collected on 
recurrence of diverticulitis.  If the patient was admitted at any time after the index presentation, the 
time to recurrence, management and need for intervention was recorded. Patient deaths during the 
study period were also recorded. 
 
All the data was then analysed using IBM SPSS Statistical Analysis Software package. The data was 
then analysed for differences in conservative management and surgical interventions.  Surgical 
intervention was further subdivided into emergency and elective intervention.  It was also divided on 
the type of procedure performed.  The total patient population was then divided into subgroups, 
including patients with diabetes, autoimmune diseases, patients on regular NSAIDS, steroid 
medications and immunomodulatory drugs.   
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Comparison of BMI and weight in these subgroups was performed using Pearsons Chi Squared test 
with a p value <0.05 considered statistically significant.  Differences between in subgroups were 
performed using a 2 sided Students t-test, with a with a p value <0.05 considered statistically 
significant, where sample size was less than 30.  In comparing proportions with sample size greater 
than 30, the significance of difference between 2 proportions was calculation using a 2 tailed Z-test, 




-   Patient Demographics 
 
A total of 1299 patients were included for analysis. Table 1 lists the patient demographics for the study 
population.  There were 583 males and 716 Females.  There were no significant differences in age in 
the two genders.  
 
Table 4 - Demographics of patients with diverticulitis 
Demographics Patients (n) Standard 
Deviation/Range 
Total 1299  
- Male 582 (44.8%) 
- Female 716 (55.8%) 
   
Median Age   
- Male 59.0 (21-98) 
- Female 67.0 (18-98) 
   
Mean Age 63.88 +15.11 
- Avg Age Male 59.78 +15.51 
- Avg Age Female 67.22 +13.93 
 
-  Method of Initial Diagnosis 
 
Accuracy of clinical diagnosis of diverticulitis varies, with up to 37% of diagnosis changing with cross 
sectional imaging[230].  Cross sectional imaging is the most accurate way of confirming diagnosis and 
staging disease at time of diagnosis.  The method of diagnosis for patients in the study period is listed 
in Table 2.  A total of 948 patients were diagnosed by cross sectional CT scan at initial presentation, 
representing 72.92% of the total population of patients with diverticulitis.  There were 168 patients 
who underwent immediate surgery without prior cross sectional imaging.  Only 6% of patients had a 
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clinical diagnosis of diverticulitis at index presentation, without any confirmatory cross sectional 
imaging. 
 
Table 5 - Method of initial diagnosis 
Method of Initial Diagnosis n % 
CT 948 72.9 
Surgical Pathology/Surgery (including Laparoscopy) 168 12.9 
Clinical 78 6.0 
Colonoscopy 53 4.1 
Barium Enema 48 3.7 
MRI 1 0.1 
Other 3 0.3 
Total 1299  
 
-  Nature and location of disease at presentation 
 
The nature of the disease at presentation for patient who had a CT scan on admission is shown in 
Table 3.  There were 533 patients with uncomplicated disease and 415 patients with complicated 
disease. Of the patients with complicated disease, 93 patients (22.4%) had more than one pathology 
found on the CT report.  The location of diverticulitis was also noted on the CT report.  The sigmoid 
colon was involved 90.3% of cases. 
 
Table 6 –Nature of Disease at Presentation 
 N % 
Total 1299  
Total with CT at Initial Presentation 948 100% 
Uncomplicated 533 56.2% 
Complicated 415 43.7% 
- Perforation 201 48.4% 
- Abscess 172 41.4% 
- Fistula 29 6.9% 
- Inflammatory Mass 38 9.1% 
- Stricture 18 4.3% 
- Obstruction 10 2.4% 
   
Location of Diverticulitis    
- Right Colon 20 2.1% 
- Transverse Colon 9 0.9% 
- Left Descending Colon 57 6.1% 
- Sigmoid Colon 856 90.3% 
- Rectum (inc Rectosigmoid Jn) 3 0.3% 




-  Management and colonic evaluation 
 
Of the 1299 patients, a total of 321 underwent surgery or an interventional radiological procedure at 
either index presentation or in subsequent follow-up.  This is outlined in Table 4.  At index admission, 
1090 patients (83.9%) were managed conservatively, while 209 (16.1%) had an emergency procedure.   
 
Of the 1090 patients managed conservatively at index admission, 106 patients (9.7%) subsequently 
had an elective procedure.  Of these, 71 (67%) were for persistent symptoms, 11 (10.4%) were for a 
colonic stricture, 23 (21.7%) were for fistulae including colovesical fistulae, 1 was for persistent 
recurrent bleeding.   There were an additional 6 patients who could not be classified into the above, 
due to lack of documentation regarding the procedure performed, or because of surgery performed 
in the past, prior to study commencement with lack of accurate notes.  
 
 A total of 32 patients underwent insertion of a percutaneous drain under radiological guidance.  All 
except one were performed in an emergency setting.  Of these 32 patients, 8 (25%) went on to have 
emergency surgery for failure of management with percutaneous drain.  These patients were included 
in the final surgical procedure rather than percutaneous drainage category. A total of 24 patients were 
managed by percutaneous drain alone. 
 
Table 7 - Management of Patients 
 n % 
Conservative Management at Index Admission 1090 83.9% 
Emergency Procedure at Index Admission 209 16.1% 
• Colectomy and Anastomosis 67 32.1% 
• Hartmann’s Procedure 111 53.1% 
• Percutaneous Drainage 23 11.1% 
• Laparoscopy / Other 8 1% 
   
Elective Procedure after Index Admission 106 9.7% 
• Colectomy and Anastomosis 71 66.9% 
• Hartmann's Procedure 32 30.1% 
• Percutaneous Drain 1 0.9% 
• Laparoscopy / Other 2 1.8% 
   
Unknown / Historical Procedure 6 1.8% 
   
Total Procedures 321  
Total Colectomy and Anastomosis 138  
Total Hartmann's Procedure 182  
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Total Percutaneous Drain 24  
Total Laparoscopy / Other 10  
 
 
Of all patients, 788 (60.7%) of patients had a subsequent colonic evaluation at Christchurch Public 
Hospital following the index hospital admission.  This is shown in Table 5.  For 511 patients no report 
for any colonic evaluation could be found after the index hospital admission on the hospital records.  
These could have been evaluated at a private institution.  No report was available at time of audit.  
 
Table 8 - Colonic Evaluation of patients with AD 
Colonic Evaluation after diagnosis 788 60.7 
- Barium Enema 86 6.6 
- Colonoscopy Including Flexible Sigmoidoscopy 625 48.1 
- Colonoscopy prior to index admission 14 1.1 
- CT Including Colonography 63 4.8 





Of the 1299 patients, 238 patients had a further admission for recurrence of diverticulitis within the 
study period, representing 18.3% of all patients.  This includes all patients with recurrences of 
diverticulitis after surgery.  Of these patients, 67 (5.15%) went on to develop a second recurrence, and 
20 (1.54%) developed a third recurrence.  Only 11 patients had more than 3 recurrences.  Recurrent 
diverticulitis is further discussed in Chapter IV. 
 
Patient factors potentially influencing disease course  
 
-  Chronic illness and medications 
 
The presence of coexisting chronic illness and the use of regular NSAID, corticosteroid and 
immunosuppressive drugs are shown in Table 6.  Patients could only be divided into uncomplicated 
and complicated disease if there was a CT scan performed at index admission.   The p values were 
calculated using a two tailed, two proportion z-test for significance of difference between 2 
independent proportions. The Null hypothesis is that there is no difference in incidence of complicated 
and uncomplicated disease, with the alternative hypothesis being that there is a difference. 
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There were a total of 107 patients with diabetes and 29 with autoimmune diseases.  There were 126 
patients taking an oral corticosteroid regularly, and 435 patients taking an NSAID regularly.  
Additionally, 25 patients (1.94%) took 2 or more NSAIDs regularly, 56 patients (4.3%) took an NSAID 
concurrently with a corticosteroid, and 14 patients (1.1%) took an NSAID concurrently with another 
immunosuppressive drug. 
  
There were no significant differences in the proportions of uncomplicated and complicated disease in 
all the subgroups examined, except for patients with Diabetes.  Diabetics were significantly more likely 
to have uncomplicated disease at presentation (p=0.013).  There were no significant differences in 
rates of uncomplicated and complicated disease for patients on regular NSAIDs.  NSAIDS were not 
associated with higher risk of complicated disease.   
 
Table 9 - Effect of Chronic Illnesses and Medications on Nature of Diverticulitis at initial presentation 
 n % Uncomplicated Complicated p 
Total 1299  533 415  
      
Diabetes 107 8.24 58 26 0.013 
Autoimmune Disease 29 2.23 15 11 0.878 
Regular Steroid  126 9.69 51 42 0.773 
- Prednisone 
<10mg/day 
48 38.09 18 16 0.694 
- Prednisone 
>10mg/day 
66 52.38 29 25 0.701 
- Dexamethasone 12 9.52 2 3 - 
Regular NSAID s 435 33.48 181 135 0.644 
- Aspirin (Low Dose) 367 84.36 165 106 0.067 
- Aspirin (Full Dose) 3 0.68 2 1 - 
- Diclofenac 28 6.43 14 11 0.982 
- Ibuprofen 24 5.51 11 12 0.411 
- Naproxyn 7 1.61 3 4 - 
- Piroxicam 1 0.22 1 0 - 
- Indomethacin 1 0.22 1 0 - 
- Celecoxib 1 0.22 1 0  
Other Immunosuppressants 26 2.01 17 11 0.627 
- Adalimumab 1 3.84 0 1 - 
- Azothioprine 7 26.92 6 0 - 
- Colchicine 1 3.84 1 0 - 
- Ciclosporin 1 3.84 1 0 - 
- Leflunomide 1 3.84 0 1 - 
- Mesalazine 2 7.69 1 1 - 
- Methotrexate 13 50 6 4 - 
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Patients were then analysed method of management against presence of diabetes, autoimmune 
diseases, and use of medications.  This is summarised in Table 7.  There were no significant differences 
in conservative management and surgical intervention in all of the subgroups examined.  Patients with 
chronic illnesses and on NSAIDS, steroids and other immunomodulatory drugs were no more likely to 
be managed surgically than patients without these factors. There was a trend towards more 
interventions in patients taking regular NSAIDS, but this was not statistically significant.   
 

















Diabetes 107 81 (75.7) 26 (24.3%) 0.918 13 (50%) 13 (50%)  0.065 
Autoimmune 29 20 (68.9) 9 (21.1%) 0.425 5 (55.5%) 4 (44.5) 0.700 
NSAIDS 435 304 (69.9%) 131 (30.1%) 0.086 72 (54.9) 49 (45.1%)  0.062 
Steroids 126 91 (72.2%) 35 (27.8%) 0.401 22 (60%) 13 (40%) 0.727 
-Prednisone <10mg 48 35  13  0.698 8 5  
-Prednisone >10mg 66 45 21 0.169 1 12  
Other 
Immunosuppressant 
29 25 (86.2%) 4 (13.8%) 0.627 0 4 0.994 
 
 
For patients who had a surgical procedure or an interventional radiological procedure, the procedure 
performed and relation to chronic diseases and medications was recorded.  This is shown in the Table 
8 below.  There were no significant differences in proportions of patients in intervention categories in 




Table 11 - Influence of Chronic Illness and Medication on Type of Intervention 
 Colectomy + Anastomosis Hartmanns Laparoscopy Percutaneous Drain 
Total 138 182 4 24 
Diabetes 11 (7.53%) 12 (8.11%) 1 (25%) 2 (8.33%) 
Autoimmune 3 (2.05%) 6 (4.05%)  0 
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- Weight and BMI 
 
Patients who underwent a CT scan had BMI, BSA, height and weight calculated using the methods 
outlined above.  Out of a total of 948 patients who had CT  at index presentation, a total of 849 had 
images available on a Picture Archiving system (PACS) to assess and measure cross sectional images 
for calculation of Body Mass Index.  There were 99 patients who had a report only, and did not have 
electronically retrievable images that could be used to calculate BMI.   
 
Of all patients, 3.9% were classified as underweight, with BMI <20 kg/m2.  Approximately 16.5% of 
patients were classified as normal, with a BMI between 20 and 25 kg/m2.  A significant proportion of 
patients with diverticulitis were overweight and obese.  Approximately 79.6% of all patients had a BMI 
higher than 25, with 55.2% of patients classified as Obese (BMI>30 kg/m2).  Figure 2 shows the 
distribution of BMI for all patients with diverticulitis.   
 
NSAIDS 53 (36.30% 57 (38.51%) 2 (50%) 9 (37.5%) 
Steroids 17 11.64%) 14(9.46%)  3 (12.5%) 
-Prednisone <10mg 5 (3.43%) 8 (5.41%)  0 
-Prednisone >10mg 11 (7.53%) 7 (4.73%)  2 (8.33%) 
Other Immunomodulators 4 (2.74%) 5 (3.38%)  1 (4.17%) 
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Figure 2 - Histogram of BMI of patients with Acute Diverticulitis 
 
  
The patients with calculated BMI were then further subdivided into nature of disease at presentation, 
use of studied medications, presence of autoimmune disease and diabetes, management of disease, 


























Patients with a BMI of <18 are considered underweight.  Patients with BMI between 18-25 are 
considered normal, BMI between 25 to 30 are considered overweight and BMI> 30 are considered 
obese.  The patients with a calculated BMI were then classified into these categories.  Table 10 below 
shows the distribution of these patients against gender, nature of disease at presentation, 
management and recurrence.  Comparison was then made between obese patients (BMI>30) to non 
obese patients (BMI<30) and tested for significance of the difference between the two proportions as 
















Overall 63.87 89.29 31.10 
- Male 59.77 104.38 32.71 
- Female 67.21 76.52 29.74 
Uncomplicated Diverticulitis 60.75 90.92 31.86 
Complicated Diverticulitis 62.81 89.85 30.88 
Diabetic 65.44 96.04 33.52 
Autoimmune Disease 65.01 88.06 31.50 
Regular Steroids 67.23 83.08 30.45 
Regular NSAIDs 67.26 87.56 30.89 
Other  Immunosuppressive Drugs 64.55 86.73 31.21 
Surgical Intervention 63.59 88.30 30.58 
- Emergency Surgery 63.91 86.60 29.81 
- Elective Surgery 62.69 91.99 32.13 
Surgical Procedure    
- Colectomy + Anastomosis 61.20 88.67 31.03 
- Hartmann’s 64.20 90.49 30.65 
- Percutaneous Drainage 70.13 78.51 28.74 
- Laparoscopy 67.25 101.53 34.37 
    
Recurrent Diverticulitis 61.15 91.57 31.75 
Malignancy 69.733 82.25 28.49 
Death 76.99 79.55 27.96 
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Table 13 - Influence of BMI on Risk Factors and Management of Acute Diverticulitis 
    BMI      
 Total < 18 18-25 25-30 <30 % >30 % p 
Total 849 13 160 206 379 44.6 470 55.3  
Male 389 4 52 84 140 35.9 249 64.1 <0.001 
Female 460 9 108 122 239 51.9 221 48.1  
          
Uncomplicated 485 11 83 103 197 40.6 288 59.4 <0.0002 
Complicated 364 6 91 85 182 50.0 182 50.0 0.3124 
          
Diabetes 84 0 11 13 24 6.3 60 12.8 0.0018 
          
Conservative Rx 624 10 102 145 257 67.8 367 78.9 0.0007 
Perc Drain 31 1 8 10 19 5.1 12 2.5 0.0574 
Surgery 216 2 53 51 106 28 110 23.4 0.129 
- Emergency 133 2 32 36 70 18.5 63 13.4 0.0435 
- Elective 83 0 19 15 34 9 49 10.4 0.4783 
          
Recurrences 238 3 31 46 80 21.1 115 24.5 0.2473 
- 2 Recurrences 59 1 10 14 25 6.6 34 7.2  
- 3 Recurrences 19 0 4 3 7 1.8 12 2.5  
- >3 
Recurrences 
11 0 1 2 3 0.8 8 1.7  
- Recurrence 
After Surgery 
19 0 4 5 9 2.4 10 2.1 0.8088 
          
 
There were 9 patients who initially underwent a percutaneous drainage procedure, and then 
subsequently had surgery.  While overall there was no significant difference in rates of obesity 
between males and females, a male patient was significantly more likely to be obese at initial 
presentation.   
 
Obese patients were significantly more likely to have uncomplicated disease at initial presentation.  
Obesity did not have a significant effect on incidence of complicated disease at presentation.  Obese 
patients were significantly more likely to be diabetic. Obese patients were significantly more likely to 
be managed conservatively, and were significantly less likely to undergo emergency surgery.  There 
was no significant effect of BMI on rate of elective surgery.  Of the patients with CT proven diverticulitis 
at index admission, 248 patients developed recurrent diverticulitis in the study period, accounting for 
28% of all patients.   
 
Figure 3 below shows the estimated rate of obesity among patients with acute diverticulitis against 
estimated obesity rates in New Zealand.  Obesity rates in New Zealand were obtained from the 
Ministry of Health Social Indicators report on Obesity [281].  In all subgroups, obesity was significantly 





-  Mortality 
 
There were a total of 107 deaths during the study period, representing 8.23% all patients over a 12 
year period.  Not all deaths were directly related to diverticulitis. On subgroup analysis there was no 
significant effect of having Diabetes, Autoimmune diseases, or taking regular NSAIDS, steroids and 
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Despite its prevalence, risk factors for development of acute diverticulitis are not well understood.  
There is significant heterogeneity in the literature about potential risk factors.  These include lifestyle 
factors, use of concurrent medications and previous diverticulitis.   
 
The prevalence of obesity is increasing in western societies.  Obesity has long known association with 
development of chronic diseases such as Type 2 diabetes, hypertension, Osteoarthritis, Obstructive 
Sleep apnoea, Gastroesophageal reflux disease etc. Obesity has long been associated with increased 
risk of infection.  In surgical patients, obesity increases the risk of surgical site infection by up to 2.5 
times[282].  
 
Adipose tissue have a significant neurohormonal function that is only just now beginning to be 
recognised.  Adipose cells release a variety of inflammatory mediators, including Leptin, Adiponectin, 
cytokines and chemokines[283].  Leptin has been recognised as regulator of CD4+ T cell mediated 
inflammation[225].  Patients with genetic deficiency of Leptin have significant immune system 
dysfunction associated with severe obesity, and are increased risk of death from infectious 
causes[284].  Obesity has been associated with increased risk of surgical site infections, nosocomial, 
odontogenic, respiratory, Urogenital, biliary, bone and joint as well as skin infections [285].  Adipose 
cells clearly have a role in the mediation of inflammation. 
 
The role of obesity in diverticulitis has been studied.  Anecdotally, surgeons have noted that the 
patients undergoing surgery for diverticulitis were obese. In a review of the American College of 
Surgeons NSQIP Database, Morbidly obese patients were younger at presentation when undergoing 
surgery for diverticulitis, and had higher preoperative systemic inflammatory response syndrome 
(SIRS)/Sepsis and Septic shock[286].  Smaller studies have shown an increased risk of complicated 
diverticulitis in obese patients[103, 185, 220, 221, 287].  Conflictingly, other studies have not shown 
any increased risk[288, 289].  
 
Many of these studies were performed at a time when cross sectional imaging was not routinely used 
in the diagnosis of diverticulitis.  This unfortunately places significant bias on the available literature, 
as up to 37% of clinical diagnosis of diverticulitis changes with cross sectional imaging[230].  Our study 
represents the largest study of patients with CT proven diverticulitis in the literature to date.   
 
Obesity is a significant problem in our society.  According to the New Zealand Ministry of Health Adult 
Nutrition Survery 2008/09, 27.8% of adults over the age of 15 were obese[290].  Our data shows that 
the incidence of obesity in patients with acute diverticulitis is much higher than the general 
population. In our study, about 80% of the patients with diverticulitis had a BMI greater than 25, and 
about 55% of patients were clinically obese.   
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In our study, there was no increased incidence of complicated disease in obese patients.  There was 
however, a significantly higher proportion of obese patients with uncomplicated disease at index 
presentation.  Surgery is generally reserved for patients who have failed conservative management 
and for complicated disease.  Interestingly, while there was no increased risk of complicated 
diverticulitis in obese patients, there patients were significantly more likely to be managed 
conservatively, and significantly less likely to undergo emergency surgery.  
 
The cause of this discrepancy is not immediately clear.  Obese patients are clinically more difficult to 
examine[291].  Peritoneal signs may be masked or underestimated on serial examinations due to 
presence of a large abdominal wall.  Surgery on the obese is also technically more difficult, and is 
associated with higher risk of morbidity and mortality as well as costs associated with the surgery[276, 
292].  Due to these factors, there may be a reluctance or a higher threshold used by surgeons in 
deciding when to operate on obese patients.    
 
The effect of drugs including NSAIDS and corticosteroids have also been studied in acute diverticulitis.  
NSAIDS have long been known to have deleterious effects on the upper gastrointestinal tract by 
inhibiting the cyclooxygenase mediated prostaglandin synthesis pathway.  This results in a breakdown 
of mucosal protective barrier.  Evidence now exists that NSAIDS have the same effect on the lower 
gastrointestinal tract.  Previous studies have suggested an associated between NSAIDS and 
diverticulitis.[208, 266]  NSAIDS have also been associated with an increased risk of perforated 
diverticulitis[192, 206, 267-269].   
 
In our study approximately 34% of patients were on a regular NSAIDs.  Approximately 5% were on a 
regular NSAID and corticosteroid medication.  The commonest NSAID used was low dose aspirin.  
Almost 10% of patients were on regular corticosteroid medications with more than half of these taking 
more than 10mg per day.  We found women were more likely to be on steroid medications than men.   
There was no significant increased risk of complicated disease among regular users of these 
medications.  Use of these medications was not a statistically significant predictor for surgical 
intervention, nor was it a predictor for emergency intervention.  Our data suggests that the effect of 
these medications, if any, is modest. 
 
Diabetes mellitus is a chronic illness associated with macro and microvascular complications.  Patients 
with diabetes are more likely to have infections than non-diabetics.  Studies have shown reduced 
humoral responses as well as impaired cellular innate responses, including impaired chemotaxis and 
phagocytosis in diabetic polymorphonuclear cells[[216, 217].  Studies have suggested an increased 
prevalence of Type 2 diabetes in patients with diverticulosis[162, 163].  We hypothesized that these 
patients could have increased risk of diverticulitis and complicated diverticulitis and have an increased 
risk of surgical intervention.   
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 Our data shows that diabetic are not at increased risk of complicated diverticular disease.  There is a 
significantly higher proportion of obesity amongst diabetic patients.  This is not unexpected, as 
diabetes and insulin resistance is directly linked to abdominal fat.  Despite this, there was no 
demonstrable differences in management of these patients, nor was there a significantly higher risk 
of recurrent disease.  
 
Studies on patients with chronic autoimmune diseases such as rheumatoid arthritis have shown  an 
increased risk of diverticulitis[191].  This is could be related to use of immunomodulatory drugs rather 
than the disease itself.  We looked at the effect of these diseases on nature of disease and 
management.  The total population pool of these patients was small in our study.  No significant 
differences were found in rates of uncomplicated and complicated disease.  There was a trend towards 
more surgical interventions in this group, however, this was not statistically significant.  Autoimmune 
diseases were not a predictor for surgical intervention.  
 
The rate of malignancy after uncomplicated diverticulitis was low.  Only 0.9% of patients with 
uncomplicated diverticulitis subsequently had a colonic malignancy diagnosed in the area of concern 
on cross sectional imaging.   This is addressed in Chapter 3.  There were other colonic malignancies 
discovered incidentally, as well as later which were unrelated to the initial diverticulitis.  Overall, the 
risk of malignancy after acute uncomplicated diverticulitis was low. 
 
There are several limitations to our study.   While our overall population of patients was high, the 
numbers of patients in some subgroups were low.  These included patients with diabetes, steroids, 
and autoimmune diseases.  It may be that our study was underpowered to find a significant difference 
in these groups.  Our study only looked at regular use of NSAIDS and steroids.  There are patients who 
are intermittently on these medications. These were not included and their overall effect is unknown.  
The estimations for Body mass index and weight were based on measurements and calculations 
performed on CT scan.  There could be errors in measurement, leading to errors in final results.  In the 
validation study by Gerrarty et al., errors in measurement resulted in a maximum error of + 1.5%.  The 
calculation were based on CT scans on patients without significant pathology.  While unlikely, it is 
possible that patients with abdominal pathology may have altered body morphology, resulting in 
further error in calculations. 
 
Management of diverticulitis is evolving and changing.  Our study was an audit of patient management 
from 1998 to 2010.  Management of diverticulitis has changed somewhat since this audit, and it may 
be that our audit is a reflection of historical practices, rather than current management.  Most 
management trends are driven by what evidence was available at the time, and what most experts 
felt was safest.  This has changed significantly in management of diverticulitis.  An example of this is 
that there was a trend to operate on younger patients, because it was felt they had more virulent 
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disease, and had longer to live, therefore were more likely to get recurrent disease.  This has now 
been disproven, and does not factor into management. 
 
Our audit has a low rate of percutaneous drainage and interventional radiological procedures and a 
relatively higher rate of immediate operative intervention.  It is now routine to perform cross sectional 
imaging on all patients with suspected diverticulitis.  In the previous decade, CT scanning was reserved 
for patients who were diagnostic dilemmas, and for patients who did not respond to management as 
expected.  This may factor into decision making for management.  
 
Factoring in to the decision to operate may have been the relative novelty of interventional 
radiological procedures at the time of the audit.  It was not known then whether percutaneous 
drainage was safe in the long term in complicated diverticulitis, or whether it was just delaying the 
inevitable surgery.  When the technology was emerging during the time period of the audit, 
percutaneous drainage was initially reserved for patients who were poor candidates for surgery, as it 
was felt that this would not be as successful in the long term.  It is now known that in the long term, 
it is safe to percutaneously drain diverticular abscesses rather than proceeding to an operation and 
indeed, is the first line of management for these.  In todays practice, percutaneous drainage is more 
common, and immediate surgery is a extremely uncommon.  This is because the techniques, 
equipment, expertise and availability of these once novel treatments have become more 
commonplace.  The decision to operate varies between surgeons and this may factor into the high 




We found that the majority of patients with acute diverticulitis were overweight or obese.  This may 
be a factor in the pathogenesis of acute diverticulitis. We found that while there is no difference in 
proportion of complicated disease in the obese, they were significantly less likely to undergo surgery 
and significantly more likely to be managed conservatively.  We also found that regular use of NSAIDS 
and steroids, diabetes and autoimmune diseases were not significant predictors for complicated 
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Acute diverticulitis accounts for 152,000 hospitalisations in the US alone. Current guidelines recommend routine 
colonic evaluation after acute diverticulitis to confirm the diagnosis and exclude malignancy. However, research 
suggests the yield of colorectal cancer following CT proven uncomplicated diverticulitis may be low. In the era 
of widespread CT scanning for diverticulitis, routine colonic evaluation after diverticulitis may represent a non 
essential burden on health care resources. 
 
Methods:  
The PubMed (MEDLINE), EMBASE, BIREME, CINAHL, and the Cochrane Library databases were searched. Original 
studies of colonic evaluation after proven acute diverticulitis were included. Meta-analysis of data from included 
studies was performed using a DerSimonian Laird random effect proportion analysis.  
 
Results: 
Eleven studies from seven countries were included in the analysis. Out of a pooled population of 1970 patients, 
cancer was found in 22. The pooled proportional estimate of malignancy was 1.6% (95% confidence interval 0.9-
2.8%). Of the 1497 patients with uncomplicated diverticulitis, cancer was found in 5 (proportional estimate of 
risk 0.7% (0.3-1.4%)). Of the 79 patients with complicated disease, cancer was found in 6 (proportion estimate 
of risk 10.8% (5.2-21.0%)). 
 
Conclusions: 
The risk of malignancy after a radiologically proven episode of acute uncomplicated diverticulitis is low. In the 
absence of other indications, routine colonoscopy may not be necessary. Patients with complicated diverticulitis 





Diverticulosis and diverticulitis are significant problems in Western countries. The incidence has increased over 
the past century[1] Up to 60% of people living in industrialised countries will develop colonic diverticula [293].   
Acute diverticulitis is one of the commonest causes of acute surgical admission. It affects up to 25% of patients 
with diverticulosis. The annual costs of diverticular disease have been estimated at around 2.7 billion USD per 
year, with around 152,000 yearly hospitalizations.[4, 165] 
 
The management of acute diverticulitis has evolved over the past two decades. There is greater use of computed 
tomography (CT) to confirm the diagnosis and a trend to conservative management instead of resection [294, 
295]. Current internationally accepted guidelines and professional bodies recommend routine colonic 
evaluation after an episode of acute diverticulitis to confirm the diagnosis and exclude malignancy.[296, 297] 
However, this practice dates back to the time before wide spread use of cross sectional imaging to diagnose 
acute diverticulitis. This may be a reflection of limitations in diagnosis and diagnostic methods previously used, 
rather than a true indication of risk of malignancy. 
 
Improvement in the accessibility of CT has led to its routine use in the diagnosis of diverticulitis and its 
complications. Technological improvement in quality and resolution of CT has led to better evaluation of the 
colon in the affected segment and accurate staging of complications of diverticulitis.[298] Due to this, the role 
of routine colonic evaluation after acute diverticulitis has been questioned.  
 
Routine colonoscopy after acute diverticulitis places a significant resource burden on already stretched 
healthcare systems.[299] There is also a small, but real risk of morbidity and mortality associated with invasive 
procedures. In addition, endoscopy may be technically more difficult in these patients due to bowel spasm, 
luminal narrowing, and fixation of the colon due to inflammation and pericolic fibrosis. 
 
To our knowledge, there are no prospective, randomised trials demonstrating a benefit of routine colonic 
evaluation after acute diverticulitis. Current recommendations are based largely on small to medium sized 
cohort studies performed before the widespread use of CT.  
 
The objective of this study was to perform a systematic review and meta-analysis of published studies of colonic 
evaluation after an episode of diverticulitis to determine the yield of colorectal cancer and non-malignant 




The meta-analysis was performed in concordance with the PRISMA Statement for preferred reporting of 
Systematic Reviews and Meta-Analyses.[300] 
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Data Source and Search Strategy 
 
A search of online databases, including, PubMed (Medline), EMBASE, BIREME, CINAHL, and the Cochrane Library 
was performed. All published articles and abstracts were included. The following search terms were used: 
Diverticulitis, Colonoscopy, Acute Diverticulitis, Colon Cancer, Endoscopy, Colonography, Colonic evaluation, 
Cancer risk after diverticulitis. There was no predetermined study design type, language limit or publication year.  
 
Study Inclusion Criteria 
 
Studies were eligible if patients received direct colonic evaluation associated with an episode of acute 
diverticulitis. Studies were included if diverticulitis was diagnosed with radiological confirmation. We included 
patients who received Flexible sigmoidoscopy alone, Computed Tomographic Colonography (CTC) alone, 
incomplete colonoscopy, or contrast enema studies. All potentially relevant studies were then screened by 2 
researchers (Consultant Colorectal Surgeon and Surgical Fellow). The full texts of relevant articles were obtained. 
A further evaluation was performed of the bibliographies of the articles to identify further potentially relevant 
studies not identified in the initial search. Data from the included studies was then extracted, tabulated and 
analysed.  
 
Study Exclusion Criteria 
 
Studies were excluded where the diagnosis of diverticulitis was made solely on clinical grounds. Studies or data 
from studies was excluded if there was no direct colonic evaluation. This included follow-up of patients via 
Cancer Registry alone. Studies where the primary method of evaluation of the affected segment was from 
histopathology after surgery were excluded. Studies on emergency surgery in diverticulitis without prior colonic 




The flowchart in Figure 1 demonstrates the method of literature review. Out of a total of 691 articles identified, 






Data Synthesis and Analysis 
 
Data was extracted from included studies and tabulated. The data was then analysed using MetaAnalyst Beta 
3.13 Software[301] (Tufts Medical Center, USA). 
 
The primary outcome of the systematic review was the yield of colorectal cancer in all patients who underwent 
routine colonic evaluation after an episode of acute diverticulitis. A DerSimonian Laird random effect proportion 
analysis of this data was undertaken using MetaAnalyst 3.13 software. 
 
The included studies were then further analysed for reporting of uncomplicated and complicated diverticulitis. 
Uncomplicated diverticulitis was defined as the presence of colonic diverticular disease with localised wall 
thickening and/or stranding of pericolic fat on CT. Complicated diverticulitis was defined as; the presence of 
abscess, perforation (including any pericolic or extraluminal gas), obstruction or fistula formation, protracted 
disease with symptoms, or an associated mass lesion. Crude and pooled malignancy proportions were then 
calculated.  
 
All included studies were then analysed for reporting of non-malignant colorectal polyps and crude and pooled 




Assessment of Heterogeneity  
 
Heterogeneity in the included studies was assessed using Cochran’s Q test. The Q test was also performed on all 




Characteristics of Studies 
 
The baseline characteristics of the included studies are summarised in Table 1. Of the included studies, four were 
performed in Israel, two in Sweden, one each in Australia, New Zealand, France, USA and the Netherlands. Ten 
articles were published in full, while one article was only published as an abstract.  
 
Table 1 – Baseline characteristics of studies included in systematic review 







Pradel et.al. [302] 1997 France Prospective 
Cohort 






2004 Israel Prospective 
Longitudinal 
122 93 Early colonoscopy in 
diverticulitis.  
Hjern et.al. [304] 2007 Sweden Prospective 
Cohort 
50 50 Compared  CTC to 
colonoscopy 
Lahat et.al.  [305] 2007 Israel Prospective 
Longitudinal 
154 73 Early colonoscopy in 
diverticulitis 
Lahat et.al. [306] 2008 Israel Prospective 
Longitudinal 
306 224 Early colonoscopy in 
patients with 
protracted symptoms 
and acute diverticulitis 
Elramah 
et.al. [307]  
2010 USA Retrospective 
Longitudinal 
188 130  
Lau et.al. [308] 2011 Australia Retrospective 
Cohort 
1088 319 769 followed up by 




2011 New Zealand Retrospective 
Longitudinal 
292 205  
Chabok et.al.[310] 2012 Sweden Multicenter 
Randomised 
582 545 Primarily looked at role 





2012 Israel Retrospective 
Cohort 
220 100 Compared colonoscopy 
vs. no colonoscopy 
after acute 
diverticulitis 
Van der Wall 
et.al.[312] 
2012 Netherlands Retrospective 
Cross 
sectional 
307 205  
Total    3358 1970  
 
 
All studies had CT as the primary method of diagnosis of acute diverticulitis. One study used Ultrasound Scan 
(USS) and CT in all patients, while another used USS or CT. Three studies looked at the role of early or inpatient 
colonoscopy in acute diverticulitis. One study looked at the role of colonoscopy in protracted symptoms of 
diverticulitis. One study looked at role of antibiotics in acute diverticulitis, 1 compared CTC to Colonoscopy, and 
one study compared USS to CT. 
 
The nature of diverticular disease, methods and time of colonic evaluation reported in the included studies are 
summarised in Table 2. There was significant heterogeneity in the design as well as the primary outcomes of 
these studies.  
 
Table 2 - Nature of Disease, Methods and Time of Colonic Evaluation 
Study Diagnosis Nature of Disease Colonic 
Evaluation 
Timing 
Pradel  (1997) [302] CT and USS All acute diverticulitis Colonoscopy, 
Contrast enema 
and Surgery 
Within 120 days 
Sakhnini (2004) [303] CT  Uncomplicated and 
complicated diverticulitis 
Colonoscopy At Index admission 
Hjern (2007) [304] CT All acute diverticulitis Colonoscopy and 
CT Colonography 
Within 4 weeks 
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Lahat (2007)  [305] CT  Uncomplicated 
diverticulitis 
Colonoscopy Early (Within 6 
weeks) or 
Late(Within 1 year) 
Lahat (2008) [306] CT  Complicated (Symptoms 
failing to resolve after 1 
week of conventional 
treatment) 
Colonoscopy At index admission 
Elramah (2010) [307]  CT  All acute diverticulitis Colonoscopy Within 6 months 
Lau (2011) [308] CT  All left sided diverticulitis Colonoscopy Within 1 year 
Westwood (2011) [309] CT  Uncomplicated 
diverticulitis 
Colonoscopy Within 2 years 
Chabok (2012)[310] CT  Uncomplicated 
diverticulitis 
Colonoscopy, 
Barium Enema or 
CT Colonography 




CT All acute diverticulitis, 
excluding 
haematochezia 
Colonoscopy Within 6 weeks 
Van der Wall 
(2012)[312] 
CT, USS or 
both 
All Acute diverticulitis Colonoscopy Within 6 weeks 
 
Out of a total population of 3358, 1970 patients underwent colonic evaluation. Colonoscopy was the commonest 
method of colonic evaluation in almost all studies, followed by CTC. Two studies used either CTC or colonoscopy, 
1 study used CTC concurrently with colonoscopy. Only one study by Pradel et al[302] had a significant proportion 
of patients with surgery. In this study, patients presenting acutely with abdominal pain were assessed with CT 
and ultrasound and followed up for a final diagnosis. From this study, only patients with a final diagnosis of acute 
diverticulitis who subsequently underwent colonic evaluation were included. Patients who had emergency 
surgery at index admission, surgery without colonic evaluation and a final diagnosis other than acute 
diverticulitis were not included in the final analysis.  
 
Out of the total population pool of 3358 patients with acute diverticulitis, 1388 patients were excluded from the 
final analysis. The commonest reason for exclusion was lack of direct colonic evaluation. Where stated, the 
reported reasons for not performing a colonic evaluation included lack of radiological evidence of diverticulitis, 
refusal of consent for procedure, severe medical comorbidities precluding a safe procedure, and proceeding to 
surgical resection without prior colonic evaluation. Three studies primarily considered the role of early 
colonoscopy in diverticulitis and excluded patients with evidence of perforation on initial CT. While 769 of the 
1388 patients that did not receive colonic evaluation were followed up using regional cancer registries alone, 
they were still excluded from the final analysis.  
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The timing of colonic evaluation after an episode of acute diverticulitis is also shown in Table 2. Two studies 
performed colonoscopy at index admission. Most studies performed colonic evaluation within 6-8 weeks 
following the index attack. One study performed it within 3 months, one within 1 year and one within 2 years. 
The approach of different studies to prior evaluation of the colon was also heterogeneous. Out of the 11 included 
studies, four excluded patients who had received colonic evaluation up to one year prior to index admission[303, 
305, 306, 308] Four studies did not report if colonic evaluation had been performed prior to that related to the 
index attack.[302, 304, 307, 310] Schmillovitz et al.[311] reported 11% of patients had received a colonoscopy 
prior to the index admission for diverticulitis, but did not report the timing of this. One study specified colonic 
evaluation was performed if this had not been carried out within 1 year prior to admission.[310] Finally, one 
study considered colonic evaluation only within the study period of 4 years.[312] 
Of the 11 studies, 8 further divided patients into uncomplicated or complicated diverticulitis groups. Three 
studies were in patients with only uncomplicated diverticulitis. Only one study was targeted primarily at patients 
with complicated disease. This was performed on patients with protracted symptoms despite adequate 
treatment.  
 
Findings of Malignancy and Non Malignant Colorectal Polyps 
 
All of the 11 included studies reported the number of malignancies found. Table 3 summarises the overall finding 
of malignancies in the included studies, as well as the reported numbers of patients with uncomplicated and 
complicated disease.  
 


















Pradel (1997) [302] 26 64  na na 2 7.8% 
Sakhnini (2004)[303] 93 63  87 6 2 2.1% 
Hjern (2007) [304] 50 56  na na 0 0.0% 
Lahat (2007) [305] 73 60.3  73 0 0 0.0% 
Lahat (2008) [306] 224 na  201 23 3 1.3% 
Elramah (2010) [307] 130 63.7  115 15 3 2.3% 





 205 0 1 0.5% 




100 61.8  86 14 0 0.0% 
Van der Wall 
(2012)[312] 
205 57.3  185 21 2 1.9% 
Total 1970   1497 79 22 1.2% 
na = Not available 
Out of a pooled population of 1970 patients, a colorectal malignancy was found in 22. The crude proportion of 
encountering a malignancy was 1.12%. DerSimonian Laird proportional analysis showed a pooled proportion of 
1.6% (95% confidence interval 0.9-2.8%). There was no significant heterogeneity, the Q value was 0.938 





Seven studies reported findings of non-malignant colorectal polyps. In two studies, the polyps were further 
stratified to include advanced adenoma. Advanced adenomas were defined as an adenoma of 10 mm or greater 
in diameter, or with high-grade dysplasia, or with greater than 25% villous components. Table 4 summarises the 
findings of non-malignant colorectal polyps in these studies. Non-malignant colorectal polyps were found in 220 
patients out of a pooled population of 1125 patients. The crude proportion of finding a non-malignant polyp was 
19.5%. The estimated pooled proportion of finding a non-malignant polyp was 16.5% (95% confidence interval 
11.2-23.8%). There was significant heterogeneity, the Q value was 0.977 (p≤0.001). Figure 3 shows the Forrest 
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plot of the estimated proportion of non-malignant colorectal polyps per patient after an episode of acute 
diverticulitis. As only two studies reported advanced adenomas within this subset of colonic polyps, proportional 
analysis of this subset was not performed. 
 
Table 4 – Finding of non malignant colorectal polyps in reporting studies. 
Study Included 
Patients 
Patients with Non 
Malignant Polyps 
 (% Crude) 
Reported Histology of Polyps Found 
Sakhnini (2004)[303] 93 9(9.6 %) 11 polyps in 9 patients, 9 Adenoma, 1 TVA, 1 TVA 
with cancer 
Lahat (2007) [305] 73 5(6.8%) 8 polyps in 5 patients, 2 VA, 5 TA, 1 TVA 
Elramah (2010) [307] 130 2(1.5%) TA in 2 patients.  
Lau (2011) [308] 319 82(27.5%) TA/VA in 42%, HP 40% 
Westwood 
(2011)[309] 
205 50(24.4%) HP in 20 patients, Adenoma in 19 patients, 
Advanced adenoma in 10 patients  
Schmilovitz-Weiss 
(2012)[311] 
100 32(32%) 42 polyps, 5 HP, 36 Adenoma, 1 advanced 
adenoma 
Van der Wall 
(2012)[312] 
205 40 (19.5%) HP in 15 patients, Adenoma in 18 patients, 
Advanced adenoma in 7 patients. 
Total 1125 220 (19.5%)  






Of the 11 included studies, 3 did not classify patients into uncomplicated or complicated diverticulitis. Five 
studies reported patients with uncomplicated and complicated diverticulitis. Three studies were performed 
solely on patients with uncomplicated diverticulitis. Table 5 summarises the findings of studies reporting 
uncomplicated diverticulitis. In these 8 studies, a pooled population of 1497 patients had uncomplicated 
diverticulitis, representing 76% of the total population in all included studies. Within the 8 studies in this 
subgroup, unless performed solely on patients with uncomplicated diverticulitis, uncomplicated disease 
accounted for more than 95% of patients.  
 


















Sakhnini (2004)[303] 93 87 1 1.1% 9 10.3% 
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Lahat (2007) [305] 73 73 0 0% 5 6.8% 
Lahat (2008) [306] 224 201 0 0% na na 
Elramah (2010) [307]  130 115 1 0.9% 2 1.7% 
Westwood (2011) 
[309] 
205 205 1 0.5% 50 24.4% 
Chabok (2012)[310] 545 545 0 0% na na 
Schmilovitz-Weiss 
(2012)[311] 
100 86 0 0% 32 32% 
Van der Wall 
(2012)[312] 
205 185 2 1.1% 40 21.6% 
Total 1575 1497 5 0.3% 138 9.2% 
 
 
A colorectal malignancy was found in 5 patients. The crude proportion of the finding of a malignancy after an 
episode of acute diverticulitis was 0.3%. The pooled proportional rate of a colorectal malignancy in patients with 
uncomplicated diverticulitis was 0.7% (95% confidence interval 0.3-1.4%). There was no significant 
heterogeneity. The Q value was 0.774 (p≤0.458). Figure 4 illustrates the Forrest plot of estimated effect.  
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Out of these 8 studies, 6 reported findings of non-malignant colorectal polyps. Out of 1497 patients, 138 were 
reported to have non-malignant polyps. This however represents polyps in the total pool of patients rather than 
polyps in patients with uncomplicated disease alone. Unless the study was performed solely on uncomplicated 
diverticulitis, no study specifically reported polyps in uncomplicated disease alone. As the proportion of patients 
with uncomplicated diverticulitis within these studies was more than 95%, a reasonably accurate estimate can 
be obtained from the data. The crude proportion of non-malignant colorectal polyps at subsequent colonic 
evaluation was 9.2%. The pooled proportional estimate was 15.1% (95% confidence interval 8.7-24.9%). There 
was significant heterogeneity, the Q value was 0.977 (p≤0.001). Figure 5 shows Forrest Plot of estimated effect. 






Of the 8 studies reporting the nature of disease, 5 had patients with complicated disease. Table 6 summarises 
the findings of studies included in this group. In total there were 79 patients with complicated diverticulitis, 
representing , less than 5% of the total pool of all included patients.  
 






Malignancy % (Crude) 
Sakhnini (2004)[303] 93 6 1 16.7% 
Lahat (2008)[306] 224 23 3 13.1% 
Elramah (2010)[307]  130 15 2 13.3% 
Schmilovitz-Weiss (2012)[311] 100 14 0 0% 
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Van der Wall (2012)[312] 205 21 0 0% 
Total 752 79 6 7.6% 
 
Six colorectal malignancies were reported in these patients. The crude rate of finding a malignancy was 7.6%. 
The proportional pooled rate of finding a malignancy in this patient population was 10.8% (95% confidence 
interval 5.2-21%). Heterogeneity was not statistically significant with a Q value of 0.716 (p=0.391). As the number 
of patients was low and no study reported the specific rate of finding polyps in patients with complicated 













Routine colonic evaluation after an episode of diverticulitis has been standard practice for the past few decades, 
as reflected by recommendations of professional bodies and accepted international guidelines[296, 297, 
313],however, there is a paucity of literature supporting this practice.  
 
Prior to the widespread use of cross sectional imaging, the diagnosis of acute diverticulitis was based on clinical 
findings and contrast enema studies. The accuracy of the clinical diagnosis of acute diverticulitis is low, with up 
to 37% of diagnoses changed with cross sectional imaging.[230] While contrast enema has a high sensitivity and 
specificity for diverticulosis, accurate recognition of an associated neoplasm within a colon with diverticulitis can 
only be made about 50% of the time.[314] Contrast enema is also dependant on operator experience and the 
quality of the images obtained. The origin of the practice of routine colonic evaluation stems from these initial 
difficulties in differentiating acute diverticulitis from colorectal cancer. 
 
CT scan has revolutionised the diagnosis and management of diverticular disease. CT has a sensitivity and 
specificity approaching 99% for the diagnosis of diverticulitis and its complications.[315] CT guidance allows for 
percutaneous drainage of diverticular abscesses. Most tertiary institutions now use multidetector CT scans, 
capable of producing high resolution images with thinner slices than previously available. Improvements in 
technology has allowed for high resolution reconstruction of images in coronal and sagittal sections, leading to 
better evaluation of the target area.[298] These improvements in diagnostic accuracy have raised the question 
of the necessity of routine colonic evaluation after an episode of diverticulitis.  
 
In this systematic review and meta-analysis, the risk of encountering a malignancy with routine colonic 
evaluation after an episode of acute diverticulitis in all patients was 1.6% (0.9-2.8%). On stratifying for disease 
severity, those with complicated diverticulitis diagnosed by imaging still had a high yield of malignancy at 
subsequent colonoscopy (10.8%), however, in those with CT diagnosed uncomplicated diverticulitis, the yield 
was low (0.7%) 
 
A recent meta-analysis by Niv et al[316] of colorectal cancer screening with colonoscopy in an asymptomatic 
population showed an invasive cancer rate of 0.78% (95% confidence interval 0.13–2.97%) in a pooled 
population of 68,324 patients. Comparing this data with the present study suggests that the risk of colorectal 
malignancy after an episode of radiologically proven acute uncomplicated diverticulitis is not significantly 
different to that of the general asymptomatic population. This suggests that a selective approach to colonoscopy 
following CT proven diverticulitis may be acceptable practice. 
 
The yield of non-malignant colorectal polyps of 19.5% (11.2-23.8%) in the present study was also similar to that 
documented by Niv et al. In that analysis of screened asymptomatic individuals at least one adenoma was found 
in 19% of patients (15-23%) [316].   This finding has to be interpreted with caution however, as there was 
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significant heterogeneity evident in the present meta-analysis when polyps were considered. Of the included 
studies, only two specifically reported findings of advanced adenoma within the subgroup of colorectal polyps. 
The most widely accepted definition of advanced adenoma includes adenomas of greater than 10mm diameter, 
or with high grade dysplasia, or with more than 25% villous architecture. In the present review Van der Wall et 
al[312] and Westwood et al [309]reported advanced adenoma in 3.4% and 5.4% of patients respectively. These 
findings are once again comparable to Niv et al’s aforementioned large study of asymptomatic screened 
individuals where advanced adenoma was found in 5% of cases 
 
It has been well documented that the risk of colorectal neoplasia increases with age and therefore, age may be 
expected to influence the yield of colonoscopy following an episode of acute diverticulitis. Unfortunately, the 
vast majority of studies in the present meta-analysis did not specify the ages of the patients with colorectal 
neoplasia separately. The only included study that addressed age did not find a statistically significant difference 
in the rate of advanced colorectal neoplasia in patients less than 50 years and those over 50.[309] The median 
ages of the included study populations ranged from 57 to 64 years. This was once again similar to the age range 
in the screening population used here for comparison and reinforces the fact that the yield of malignancy at 
colonoscopy after CT proven diverticulitis is likely to be similar to that population. 
 
There is no internationally agreed acceptable yield of colonoscopy and this figure will depend on the population 
investigated. As with any invasive procedure, the indications depend on the potential risks and benefits to the 
individual patient, in addition to the resources available to the community. All invasive procedures carry a small 
but real risk of morbidity and mortality. Colonoscopy and CTC have a colonic perforation rate of 0.1-0.2% and 
0.02% for respectively.[317] There are significant regional variations and local patterns in colorectal cancer, and 
the provision of colonoscopy has to take this into account. Many countries report a gap between the provision 
of and demand for colonoscopy.[299, 318] The fact that colorectal cancer outcomes are improved with early 
diagnosis and treatment increases the importance of targeting the available colonoscopy resources to those at 
greatest risk.  
 
Many countries now offer national CRC screening programmes and faecal occult blood tests, flexible 
sigmoidoscopy and colonoscopy have all been demonstrated to be effective strategies. Non-targeted CT without 
Colonography has a sensitivity of 72% in the detection CRC.[319] Non targeted CT performed for diverticulitis 
should not be used as a substitute for CRC screening. If sufficient resource is available, colonoscopy after CT 
proven diverticulitis may present an opportunity to offer de facto screening, however, in the setting of an 
effective screening programme it is likely redundant. Given the rising prevalence of diverticular disease and the 
ageing population, a strategy of routine colonoscopy following CT proven uncomplicated diverticulitis may limit 
the timely provision of colonoscopy to those at greater risk of colorectal carcinoma.  
 
There are a number of limitations in this meta-analysis that deserve further consideration. Any systematic review 
and meta-analysis is limited by the quality of the studies included and the data from these studies. There was 
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significant variability in design and methodology in the individual studies. The patient populations studied were 
also heterogeneous, ranging from acute admissions with uncomplicated diverticulitis, to patients with persisting 
symptoms despite adequate treatment. Out of the 11 included studies, five were retrospective. The study 
populations in many reports were small with only one study containing more than 500 patients, and this 
accounted for approximately 25% of the total pooled population. Despite these differences in the population, 
design, methodology and primary outcomes amongst studies, there was no significant heterogeneity in the 
pooled estimate of malignancy from the meta-analysis. In addition, no significant heterogeneity existed for the 
pooled estimates related to the uncomplicated and complicated diverticulitis subgroups, suggesting the studies 
produced consistent estimates of the risk of malignancy. 
 
Of the 3358 patients in the 11 studies, 1388 patients were excluded from this analysis as they did not undergo 
colonic evaluation. Patients who went to surgery directly were excluded as the affected segment was removed 
hence it was neither available for colonic evaluation nor at risk of a missed cancer. Some 769 of the patients that 
did not receive colonic evaluation were followed up using cancer registry data. While this was not included in 
the meta-analysis, the cancer registry data did not suggest a high risk of CRC in these patients. In fact, when 
Westwood et al included accurate national cancer registry follow up with the group that underwent colonic 
evaluation, the rate of malignancy after acute diverticulitis dropped from 0.5% to 0.3%.[309] 
 
The timing and method of colonic evaluation were also variable. Colonic evaluation was performed at differing 
time points ranging from the initial inpatient admission with acute diverticulitis to within two years of the 
episode. Colonoscopy was the most popular method of evaluation followed by CTC. While CTC has a similar 
sensitivity to colonoscopy for colorectal cancer,[320] contrast enemas have a lower accuracy.[321] The 
heterogeneity described limits the conclusions that can be drawn from this data and a well-designed, 
prospective, multicentre study investigating the incidence of malignancy after CT confirmed diverticulitis could 
provide more conclusive evidence in the future.  
 
In using a selective approach for colonoscopy after acute uncomplicated diverticulitis, there are several other 
factors that need to be considered. The reporting of the initial diagnostic CT is operator dependent and accuracy 
will vary amongst institutions and with the experience of radiologists. There are significant regional variations in 
the incidence of CRC, and local institutions need to consider these. At the individual patient level, clinical history, 
family history and examination findings must all be considered in the decision whether or not to perform 
colonoscopy. Clinical features may exist that mandate colonoscopy irrespective of the CT findings. Most acute 
uncomplicated diverticulitis responds rapidly to treatment. Persistence of symptoms after optimal treatment 
should be an indication for further investigation. This meta-analysis focused on CRC, however other pathology, 
such as inflammatory bowel disease (IBD), may require exclusion depending on the clinical circumstances. It is 
noteworthy that the only studies considering alternative colorectal pathology also showed a very low rate of 
diagnosis of IBD after CT diagnosed diverticulitis[310, 317]. 
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Despite the aforementioned limitations, the available data presented in this meta-analysis suggest the yield of 
malignancy at colonoscopy after CT proven acute uncomplicated diverticulitis is low. This data supports a 
selective approach to colonoscopy after an episode of CT proven diverticulitis. Patients with uncomplicated 
diverticulitis have a low risk of malignancy and can be prioritised similarly to the asymptomatic population.  
Patients with complicated diverticulitis represent a much higher risk group, and should undergo routine colonic 
evaluation. However, in view of the overall paucity of high quality data, further large scale studies are needed 
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Diverticulosis is common in the older population, with up to 25% developing acute diverticulitis. After 
an initial episode of diverticulitis, most patients do not have recurrent diverticulitis. Risk factors for 
recurrence are poorly understood.  Studies have suggested an association between corticosteroids, 
Non-Steroidal Anti-Inflammatory Medications (NSAID’s) and obesity with acute complicated 
diverticulitis.  The purpose of this study was to study the effect of weight, body mass index, regular 
NSAID’s, corticosteroid, immunosuppressive medications, and chronic illnesses of diabetes and 
autoimmune diseases on risk of recurrent diverticulitis. 
 
Methods 
All patients admitted with a diagnosis of acute diverticulitis (AD) from January 1998 to Dec 2010 at 
Christchurch Public Hospital were included.  Medical records were analysed for chronic illnesses, 
regular use of immunomodulatory drugs, management and follow-up.  Using computerised 
tomography of the abdomen (CT) data, estimation was made of BMI and weight. Patients were follow-
up up to assess recurrence of diverticulitis 
 
Results 
1299 patients were identified with an initial attack of diverticulitis, of which, 238 patients had at least 
one recurrent episode (18.32%)  Recurrent diverticulitis was significantly more likely in patients on 
regular NSAIDS (p<0.001), patients with Autoimmune diseases (p=0.006), and uncomplicated disease 
at index presentation (p<0.001). Surgery and interventional radiological procedures were associated 
with a significantly lower risk of recurrence (P<0.0001). Obesity, Age, Gender, and Diabetes were not 
associated with a higher risk of recurrence.  
 
Conclusions 
Patients with uncomplicated disease at initial presentation, autoimmune disease and regular NSAIDS 
are significantly more likely to have recurrent diverticulitis.  Surgery was associated with a lower risk 






Diverticular disease is a significant problem in western countries. Up to 70% of the population greater 
than 70 have acquired colonic diverticula [7, 322].  Of these, 25-30% will develop at least one episode 
of symptomatic acute diverticulitis (AD) in their lifetime [7, 166]. Admissions for diverticulitis are 
increasing significantly in western countries, as is the incidence of complicated diverticulitis [165, 167, 
168] 
 
There has been a significant change in the diagnosis and management of diverticular disease and its 
complications over the past two decades[295]. Routine cross sectional imaging has allowed an 
accuracy of diagnosis of diverticulitis and its complications approaching 99%[323].  Cross sectional 
imaging has also allowed for percutaneous intervention with success rates similar to that of surgery 
[324]. 
 
The role of emergency surgery in acutely unwell patients, and patients with diffuse peritonitis due to 
complicated disease is clear.    The role of elective surgery for prevention of recurrent diverticulitis 
and its complications remains a very controversial area.  Up until early 2000, the American Society of 
Colon and Rectal Surgeons (ASCRS) recommended resection after 2 confirmed episodes of 
diverticulitis [325, 326].  The intention of elective surgery was to prevent further episodes of 
diverticulitis, and to prevent complicated disease in the future.   
 
The initial  rationale for this approach was based on data published in 1969 by Parks [42].  He found 
that medical management of diverticulitis was unlikely to be successful after the second episode.  His 
data showed a 70% response to medical therapy with the first episode, and only 6% response after 
the third episode, although the definition of response was not provided.  He also reported that 
mortality increased from 4.7% at first episode to 7.8% at subsequent episodes.  Interestingly, the 
recurrence in patients that underwent surgery was not assessed in his original paper.  Diverticulitis 
was also believed to be a progressive disease, and it thought that recurrent diverticulitis was likely to 
have a more virulent course than the initial episode[164]. 
 
Subsequent studies have questioned these findings and beliefs.  There is a significant paucity of 
evidence to support resection after 2 episodes of diverticulitis [295].  Medical management has been 
shown to be much more successful than initially thought, leading to an increasing shift towards 
conservative management [259].  Mathematical modelling has shown that morbidity is not 
significantly different after the 4th episode of diverticulitis than the second episode [260]. A large 
cohort study has shown that patients with recurrent hospitalizations for diverticulitis did not have a 
significantly higher risk of emergency surgery or mortality [233]. 
 
The exact rate of recurrence after a single attack of diverticulitis is not known.  Quoted recurrence 
rates in the literature range from 7% to 62%[42, 231, 237-241].  Many earlier studies were plagued 
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with methodological flaws.  Traditionally, diagnosis of diverticulitis and its recurrence was based 
largely on clinical criteria.  Up to 37% of diagnoses change with cross sectional imaging [230].  Older 
studies often report a higher risk of recurrence, and hence advocate for surgery.  Later studies that 
use routine cross sectional imaging have a narrower range of reported recurrences, but still quote 
rates of 17-42% [17-22]. 
 
The risk of recurrent episodes of diverticulitis after the first episode of recurrence is also unknown.  
Parks showed a higher risk of failure of medical management and higher mortality after the second 
episode of recurrence.  Most studies classify disease into recurrent disease without stratifying the 
number of episodes of recurrence and the individual risk.  It was initially thought that recurrent disease 
was more likely to be complicated disease [327, 328].  More recent studies have questioned this belief 
[231, 270].   
 
The shift away from surgery has also been supported by studies which show that surgery does not 
necessarily prevent recurrent diverticulitis [234].  After a seemingly adequate resection, up to 70% of 
patients have persistent diverticula on barium enema[329].  In a systematic review of literature, 
recurrent abdominal symptoms occurred in 1-10%, and re-resection was required in 0.3 -1% [234].  
Quoted recurrence rates for diverticulitis after surgery vary in the literature from 5-25% [3, 255, 325, 
329], depending on length of follow up and definition of recurrence (e.g. clinical vs radiological). 
 
Despite its prevalence, risk factors for recurrent diverticulitis are poorly understood.  There is a 
significant paucity of literature on this.  There is conflicting evidence about the extent of resection on 
recurrence, with some showing a lower recurrence with extensive resection, while others showing the 
opposite [3, 325, 329].  A rectal anastomosis has been associated with a lower risk of recurrence [3, 
330].  A C-Reactive Peptide titre greater than 240mh/L has been correlated with a higher risk of 
recurrence[231].  Several studies have suggested an association between non-steroidal anti-
inflammatory medications (NSAID) and corticosteroid medication with complicated diverticulitis [194, 
264, 268], although their effect on recurrence is unknown. 
 
Obesity is a significant problem in western societies.  Studies have also suggested an increased risk of 
complicated disease in obese patients [220, 228, 276, 287, 331]. The US Health Professional study 
showed a higher risk of diverticulitis in men with higher BMI, Waist to Hip Ratio and waist 
circumference[222].  Obesity also significantly increases costs associated with management of the 
disease and its complications [276].  The effect of obesity on the risk of recurrent diverticulitis is 
unknown.   
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The purpose of this study was to assess the effect of body mass index (BMI), weight, chronic illnesses 
including diabetes and autoimmune diseases, and use of regular use of medications including NSAID’s, 




A retrospective analysis was performed of all patients admitted with Diverticulitis using methodology  
described in Chapter 2.  Estimation of BMI was obtained using Cross sectional CT data as described in 
Chapter 2.   
 
Data was collected on recurrence.  Recurrent diverticulitis was defined as a radiologically, surgically 
or histopathologically confirmed diagnosis of acute diverticulitis after discharge from hospital for an 
episode of AD.  If the patient was admitted at any time after the index presentation, the time to 
recurrence, management and interventions performed were recorded.  Patients with clinical and 
biochemical signs of diverticulitis but without confirmation of diagnosis with the means mentioned 
were not included in recurrence.  Patients with a final diagnosis of colitis or inflammation in the 
absence of inflamed diverticula on cross section imaging were also excluded.  Patients with a final 
diagnosis of Inflammatory Bowel disease, or Colitis of an aetiological source other than diverticulitis 
(e.g. infectious colitis, Ischaemic Colitis etc.) were also excluded from recurrence.  Patients with pelvic 
abscesses in the absence of active diverticulitis on CT were also excluded from recurrence.  
 
All data was then analysed using International Business Machines (IBM) Statistical Package for Social 
Science (SPSS) statistical analysis software.  Comparison of BMI and weight in these subgroups was 
performed using Pearsons Chi Squared test with a p value <0.05 considered statistically significant.  
Differences between in subgroups were performed using a 2 sided Students t-test, with a with a p 
value <0.05 considered statistically significant, where sample size was less than 30.  In comparing 
proportions with sample size greater than 30, the significance of difference between 2 proportions 




There were a total of 1299 patients analysed.  Of these, there were 238 patients who were admitted 
with recurrent diverticulitis after an initial episode of diverticulitis over the study period.  The 
demographics of these patients are given in the table below.  Of all the patients with recurrence, only 
224 (85.3%) had a CT scan at the index presentation.  All patients with recurrence had confirmation 
with CT scanning at time of admission for recurrence. Of the 238 patients with confirmed recurrences, 
a total of 195 patients had images retrievable though an electronic Picture Archiving system (PACS) to 
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allow for calculation of Body Mass index.  There were 43 patients who had a CT report only or had 
imaging performed at a different institution that did not allow access to retrievable cross sectional 
imaging. 
 
Table 1 shows demographics of patients with recurrence, compared to patients without recurrence.   
There were no significant differences in gender or age. 
 
Table 10 - Demographics of patients with recurrent diverticulitis 




Total 238 1061 
- Female 124 (52.1%) 593 (55.84%) 
- Male 114 (47.9%) 468 (44.16) 
   
Median Age   
- Female 66.00 (38-93) 67.92 (18-98) 
- Male 54.84 (21-90) 60.00 (23-99) 
   
Mean Age   
- Female 65.81 67.51 
- Male 56.09 60.00 
   
 
Figure 1 shows the frequency of incidence of recurrent diverticulitis in all patients with an index 
presentation with AD.  This includes patients managed conservatively and surgically.  Of the 238 
patients who developed recurrent disease, 67 (28%) patients went on to a second recurrence.  Of 
these patients, only 20 patients developed a third recurrence. Of these 20, only 11 had more than 3 
episodes of recurrent diverticulitis.  Out of 1299 patients with AD, 18.3 % (238 patients) developed a 
first recurrence, 5.2% (67) developed a second recurrence, and 1.5% (20) developed a third 
recurrence.  Only 0.8% of patients had more than three recurrences.   The risk of recurrence decreased 
with every episode, and greater than 3 recurrences was rare. 
 


























- Recurrent Diverticulitis and Patients undergoing Surgery  
 
Of the 1299 patients, 24.7% (321) underwent a surgical procedure including Interventional radiological 
procedure during the study period.  Of these, 65.1% (209) were Emergency procedures, and 34.5% 
(106) were planned Elective procedures.   There were 6 (0.4%) patients who had surgery at an 
institution other than ours, details of which could not be obtained 
 
Table 2 summarizes the type of procedure and recurrent diverticulitis after the procedure.  There were 
a total of 15 confirmed recurrences after Surgery and Interventional Radiological procedures.  Of 
these, there were a total of 10 confirmed recurrences after a colectomy, representing 3.4% of all 
colectomies, and 3.1% of all interventions.  There were 4 confirmed recurrences after percutaneous 
drainage, representing 16.7% of all percutaneous drainage procedures.  There was one recurrence in 
a patient who underwent a laparotomy and washout, without colectomy in an emergency setting.  
  
Table 2 - Type of surgical procedure and recurrence of diverticulitis 
Procedure n Recurrence  % No 
Recurrence 
% 
Total Surgery 321 15 4.67% 306 96.33% 
Emergency Surgery 209 10 4.7% 199 95.3% 
- Percutaneous Drain 23 3 13.1% 20 86.9% 
- Hartmann's Procedure 111 4 3.6% 107 96.4% 
- Colectomy and 
Anastomosis 
67 2 2.9% 65 97.1% 
- Laparoscopy / Other 8 1 12.5% 7 87.5% 
      
Elective Surgery 106 5 4.7% 101 95.3% 
- Percutaneous Drain 1 1 100% 0 0.0% 
- Hartmann's Procedure 35 2 5.7% 33 94.3% 
- Colectomy and 
Anastomosis 
74 2 2.7% 72 97.3% 
- Laparoscopy/Other 2 - 0.0% 2 100% 
      
Unknown Procedure  6 - 0.0% 6 100% 
      
No Intervention 978 223 22.8% 755 77.2% 
      
Colectomy 287 10 3.5%   
- Emergency 178 6 3.4%   
- Elective 109 4 3.7%   
      
 
There were 24 patients who underwent an interventional radiological procedure, 23 as an emergency, 
and 1 in an elective setting.  There were 7 patients who had laparoscopy and washout as an 
emergency, and one electively.  One patient underwent a laparotomy and washout as an emergency.  
There were also 6 patients who had undergone a colectomy historically prior to the commencement 
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of the study. While this most probably was a colectomy, no further information on the nature of the 
procedure could be obtained.  There were no recurrences in this group.  
 
Of the patients undergoing surgery, only 4.7% developed a recurrence, while 17.9% of patients 
without surgery developed recurrence.  Patients who had surgery were significantly less likely to 
develop a recurrence than patients without intervention (p<0.0002).  There was no significant 
difference in recurrence rates between the emergency and elective intervention groups (p=0.9785).  
Overall, percutaneous drainage and laparoscopic washout had higher incidence of recurrence, but this 
could not be tested for statistical significance due to small numbers.   
 
- Emergency Surgery and Recurrent Diverticulitis 
 
Of the 1299 patients admitted with AD, 209 (16.1%) underwent emergency surgery during the study 
period.  Of these, 191 (14.7%) underwent an emergency surgery at index admission.  Of the 1108 
patients managed conservatively at index admission, 109 patients underwent elective surgery.  Only 
18(1.62%) of patients out of the 1108 patients managed conservatively at index presentation required 
further emergency surgery for diverticulitis during the study period.  Of the 191 patients managed 
surgically at index operation, 2 required a further surgical procedure during the study period.   
 
Figure 2 demonstrates the outcome of patients managed with emergency surgery.  Of the 209 
patients, there were 10 patients who developed recurrent diverticulitis.  Of these 10 patients, 2 


















- Outcomes of Patients Managed Conservatively at Index Admission 
 
Figure 3 outlines the outcomes of patients managed conservatively at index admission.  Conservative 
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Of these patients, 106 underwent elective surgery after index admission.  The commonest indication 
for an elective procedure was for persistent symptoms related to diverticular disease, followed by 
fistulating disease, stricture and obstruction, and finally malignancy or suspicion of malignancy.  
Within the elective surgery group, there were 5 (4.7%) confirmed recurrences.  These were all 
managed conservatively, with no further surgery in this group.  There were no second episodes in this 
group.   
 
Of the remaining 1002 patients managed conservatively, 18 required an emergency procedure during 
the study.  Overall, only 1.79% of patients managed conservatively at index presentation and not 
undergoing elective surgery required emergency surgery. 
 
- Effect of Age, Gender, Body Mass Index (BMI), Chronic Illnesses, Weight, Medications and 
Surgery in Recurrent Diverticulitis 
 
Figure 4 shows a histogram of the BMI of all patients with recurrent diverticulitis.  Of the 195 patients, 
8 (4.2%) had a BMI<20, 26 (13.4%) had a BMI between 20 and 25, 46 (23.6%) had a BMI between 25 
and 30, and 115 (58.9%) had a BMI greater than 30.  Using the World Health Organization classification 
of BMI, 82.3% of patients with recurrent diverticulitis were classified as overweight or obese.  
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Patients with recurrent diverticulitis were then compared to patients without recurrent diverticulitis 
across a number of subgroups.  These included gender, nature of disease at presentation, presence of 
diabetes and autoimmune diseases, use of regular medications, surgical intervention and type of 
procedure, presence of malignancy and death.  Table 3 summarizes the overall number of patients in 
each subgroup.  Total number of patients represents all the patients included in study, including ones 
that went straight to surgery without radiological confirmation prior to surgery.  The total number of 
patients for calculation of BMI was 849, due to lack of availability of a retrievable imaging for 
measurements and calculation.  There were a total of 948 patients who had cross sectional imaging, 
99 of whom had a report only that confirmed the diagnosis.  These are included in the data for 
diverticulitis, as it was confirmed, but cannot be included in BMI calculation due to above mentioned 
factors.   Analysis was then carried out to assess for effect of each subgroup for difference in 
recurrence. For example, Patients with BMI>30 and recurrence were compared to patients with 
BMI<30 and recurrence and assessed for significance.  Patients with Complicated disease at index 
presentation and recurrence were compared to patients with Uncomplicated disease at index 
presentation with recurrence.  For the Risk factors of Diabetes, autoimmune diseases, NSAIDS, 
steroids and immunomodulators, comparison was made of proportion in recurrence group with the 
 117 
no recurrence group.  For patients undergoing surgery, the proportion of recurrence was compared 
to overall recurrence rate to assess for significance of difference.  
 
Table 3 - Factors influencing Recurrence 
 
 
Total Recurrence No 
Recurrence 
p 
Total (All patients) 1299 238 1061  
BMI (n=849)     
- BMI<30 379 80 299  
- BMI>30 470 115 355 0.2473 
Nature of Disease (n=948)     
- Uncomplicated 
Disease at initial 
Presentation 
533 159 374 <0.001 
- Complicated Disease 
at initial Presentation 
415 79 336  
Diabetes 107 17 90 0.462 
Autoimmune 29 11 18 0.006 
NSAIDS 435 105 330 0.008 
Steroids 126 29 97 0.152 
- Prednisone <10mg 48 10 38 0.647 
- Prednisone >10mg 66 12 54 0.176 
Other Immunomodulators 26 6 20 0.444 
Surgery 321 15 268 0.0002 
- Emergency 209 10 199 <0.001 
- Elective 106 5 101 <0.001 
     
 
Overall recurrence rate was 18.3%.  This is comparable to published literature.  There was no increased 
proportion of recurrence in patients with a BMI>30.  At index presentation, 533 patients out of 948 
(56.2%) had uncomplicated disease.  Of all patients with recurrent disease, 159 (66.8% of all 
recurrences) had uncomplicated disease at index presentation. There was a statistically significantly 
higher proportion of patients with uncomplicated disease at index presentation with recurrences 
compared to all uncomplicated disease at index presentation (66.8%  vs 57.1%).  The proportion of 
complicated disease at index presentation was not significantly different at initial presentation and at 
recurrence.  
 
The proportion of patients with autoimmune diseases was significantly higher in the recurrence group 
than in all patients at index presentation.  There was no increased risk in patients with Diabetes, 
steroid medications and other immunomodulatory.  Patients on Non-Steroidal medications were 
significantly over-represented in patients with recurrence, with 44.1% of patients in recurrence group 
being on regular NSAIDS, vs 33.8% in all patients at index presentation.   
 
There were only 15 recurrences in patient who had undergone surgery representing 4.6% of all 
patients who had undergone surgery.  There were 223 recurrences in 978 Patients who had not had 
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surgery, representing 22.8% of patients.  Patients who had surgery were significantly less likely to be 
in the recurrence group (p<0.0002).  The total number of patients with recurrence after surgery was 
too small to perform subgroup analysis, but overall, there did not seem be any difference in 
emergency vs elective surgery on rate of recurrence.   
 
Table 4 shows the estimated mean age and weight of patients across all studied risk factors, adjusted 
for recurrent diverticulitis.  Overall, there were no statistically significant differences in mean age or 
weight across the groups studied.  
 




Malignancy after Diverticulitis and Recurrence 
 
There were a total of 42 patients who had a diagnosis of a malignancy during the study period.  In the 
colon there were 22 Colon cancers, 3 Rectal cancers, 1 anal cancers.  These represent 2% of all patients 













 p(Weight)  
Overall 61.1 91.6 64.7 88.6 0.171 0.239 
- Male 56.0 107.0 60.6 103.5 0.118 0.233 
- Female 65.8 77.7 67.5 76.1 0.648 0.534 
Uncomplicated Diverticulitis 60.4 90.7 60.8 91.0 0.121 0.382 
Complicated Diverticulitis 60.5 94.3 63.3 88.6 0.544 0.441 
Diabetic 63.1 99.6 65.8 95.1 0.235 0.423 
Autoimmune Disease 59.1 100.3 68.5 79.5 0.521 0.193 
Regular Steroids 62.5 89.9 68.6 80.5 0.233 0.335 
Regular NSAIDs 62.8 92.1 68.6 85.8 0.131 0.275 
Other Immunomodulators 60.9 91.4 64.0 89.5 0.342 0.673 
Surgical Intervention 59.3 96.0 64.8 85.1 0.235 0.253 
- Emergency Surgery 59.8 95.3 64.6 84.1 0.141 0.532 
- Elective Surgery 58.4 99.7 64.9 86.8 0.144 0.344 
Surgical Procedure       
- Colectomy + 
Anastomosis 
57.1 95.2 63.2 83.6 0.234 0.646 
- Hartmann’s 63.0 95.6 64.3 89.5 0.255 0.540 
- Percutaneous 
Drainage 
60.6 98.0 74.8 70.1 0.582 0.380 
- Laparoscopy 71.5 106.8 63.0 90.9 0.409 0.375 
Malignancy 68.0 80.1 69.9 82.6 0.482 0.356 
Death 76.0 80.9 77.1 79.2 0.399 0.363 
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with diverticulitis.  There were also 6 diagnoses of Prostate cancer, 3 bladder cancers, 4 breast cancers, 
2 haematological cancers and 1 Lung cancer.  
 
Only 4 patients had malignancy diagnosed within a year of diagnosis of diverticulitis, and all of these 
had an initial presentation with complicated disease.  Two of these patients had emergency surgery 
at presentation, with finding of malignancy on histology.  One had a colovesical fistula that underwent 
urgent elective surgery, with finding of malignancy on histology.  The other one had an urgent elective 
operation for a stricture, initially managed as benign diverticular stricture.  Histology showed a 
malignancy in the sticture. The rest of the colon cancers were diagnosed more than a year after index 
presentation, and ranged from appendiceal and right sided tumors (n=10), Transverse colon tumors 
(n=3), Left sided cancers (n=5), Rectal cancers (unrelated to initial are of concern on CT) (n=3), Anal 
cancer (n=1).  
 
There were 8 malignancies identified in patients with recurrent diverticulitis, representing 3.4% of all 
patients with recurrence. Of these, there was 1 prostate adenocarcinoma, 1 Bladder tumour with 
invasion into sigmoid colon, and 1 anal canal carcinoma.  There were 5 colonic carcinomas (2.1%).  Of 
these, 1 was a focal carcinoma in a polyp in the rectum, and 1 was a right colon cancer, both unrelated 
to initial diverticulitis.  Only 3 malignancies were identified in area of recurrent diverticulitis, 
representing an overall malignancy rate of 1.26%.  These were diagnosed at 2 years, 4yrs and 9 years 
after index presentation.  All these 3 patients had colonoscopy after index presentation, with no 




Recurrent Diverticulitis is relatively uncommon.  Of all patients with AD, between 25-30% will develop 
a recurrent episode [7, 166].  Risk factors for recurrence remain poorly understood.    
 
Management of diverticulitis is changing significantly, with an increasing emphasis on conservative 
management.   Elective surgery for diverticulitis based on a fixed number of episodes has now largely 
been abandoned in favour of a patient centric model, with surgery being offered only for severely 
symptomatic patients[332].  This is reflected by most recent international guidelines [254, 333].  
 
In our study, recurrent diverticulitis affected 238 of 1299 (18.3 %) patients.  This is consistent with the 
reported rate of 10-25% in literature [3, 255, 329, 330] .  Our data shows that the risk of recurrent 
diverticulitis decreased with every subsequent attack.  Of all patients with diverticulitis, 18% 
developed one recurrence, 5% developed 2 recurrences, and only 1.5% developed 3 recurrences.  
More than 3 recurrences were rare. 
 120 
 
We have attempted to identify risk factors for recurrent diverticulitis.   Some were found to be 
significant, while others were not, as discussed below. 




Obesity is a significant problem in New Zealand, with 27.8% of adults over the age of 15 being 
obese[290].  Obesity has been associated with in increased risk of diverticulitis [222, 334], and 
increased physical activity has been associated with a lower risk of complications of diverticular 
disease [224].   The effect of obesity on recurrent diverticulitis is not known.   
 
In Chapter 2, we have shown that the proportion of obese patients with diverticulitis is significantly 
higher than that of the general population, with 55% of patients with diverticulitis being obese.  In this 
study of patients with recurrent diverticulitis, obese patients accounted for about 44% of all patients.   
 
Overweight and obese patients were overrepresented in patients with recurrent diverticulitis.  Of all 
patients with recurrence, 67.6% were overweight (BMI>25) and 44.6% were obese (BMI>30).  There 
was no significant difference in the proportions of patients with BMI less than 30 and no recurrence.  
Compared to the overall NZ population, obesity is overrepresented in patients with diverticulitis and 
recurrence, but there is no significant difference in proportions of obesity amongst patients with initial 
episode of diverticulitis and patients with recurrence. .  
 
NSAIDS, Oral Corticosteroids and Immunosuppressants 
 
Oral corticosteroids, NSAIDS and opiates have been associated with complicated diverticulitis [194, 
208, 264, 268]. NSAIDS are associated with an increased risk of perforation [193, 267, 335].    NSAIDS 
are known to inhibit the Cyclooxygenase mediated prostaglandin synthesis pathways.  This affects 
inflammatory response, results in breakdown of mucosal protective barrier and may result in 
diverticulitis [194, 266].  Oral corticosteroids and immunosuppressants have well documented 
immunomodulatory effects and the risk of subsequent infection. The effect of these medications on 
recurrence of diverticulitis is not known. 
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Our data shows that patients on Non-Steroidal Anti-inflammatory medications were also significantly 
over-represented in patients with recurrent diverticulitis compared to patients without recurrence 
(44% vs 31%).  The proportion of patients on NSAIDS was also higher in patients with recurrence 
compared to index presentation (44% vs 33%) 
 
Interestingly, and somewhat counterintuitively, there was no increased risk in patients with steroid 
medications and other immunomodulatory. The cause for this is not immediately clear.  Non Steroidals 
have a role in degradation of mucosal barriers by inhibiting arachidonic acid metabolites and 
prostaglandins which normally stimulate and maintain gastric and other enteric mucosal barriers.  
NSAIDS have been shown to cause colonic ulceration and inflammation[336], activate quiescent 
inflammatory bowel disease[337, 338], and is also associated with complicated diverticulitis[269].  It 
is well known that regular NSAIDS result in loss of mucosal barriers in the Upper GI tract resulting in 
peptic ulceration. 
 
It is possible that NSAIDS result in a loss of mucosal protection of the colon, which could result in 
translocation of bacteria, or micro perforation in areas of weakness such as diverticulae.  This may 
increase risk of diverticulitis. Corticosteroids, while reducing immune responses via a cellular 
mechanism, do not have the same immediate effects on mucosa.  It may be possible that this is why 
steroids are not associated with an increased risk of recurrence.  
 
Nature of disease at index episode 
 
There were a significantly higher proportion of patients with uncomplicated disease at index 
presentation in the recurrence group, than patients with uncomplicated disease at initial presentation 
(66.8% vs 56.2%)  This difference was significant.  There was no statistically significant difference in 
proportion of patients with complicated disease at index presentation at recurrence compared to 
complicated disease at initial presentation (33.2% vs 43.7%).   
 
The cause for this is again not clear.  It is possible that a proportion of patients with severe complicated 
disease at index presentation underwent surgery. As discussed below, surgery has a much lower risk 
of recurrence.  These patients may have been excluded from the natural course of the disease. The 
number of patients with uncomplicated disease is also higher.  Overall difference between the 2 
groups is about 10%, but only the difference in the uncomplicated groups approached statistical 
significance.  It is possible that the study was underpowered for patients with complicated disease.   
 
Autoimmune disease and Diabetes 
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Autoimmune diseases result in impaired immune responses, which can exacerbate ongoing infectious 
diseases or predispose to increased risk of infection [235].  This could be related to the disease itself, 
or related to ingestion of immunomodulatory medications required to manage this disease.  Diabetes 
also has well documented effects on the immune system and risk of infection [278]. 
 
Our data shows that the proportion of patients with autoimmune diseases was significantly higher in 
the recurrence group than in all patients at index presentation (4.6% vs 1.1%). In our study, there were 
significantly more patients with chronic autoimmune diseases in the recurrence group than the no 
recurrence group (p=0.006).  There was no significant difference in proportion of Diabetes in both 
groups.  As the total number of patients with autoimmune diseases was low, no meaningful subgroup 
analyses could be performed.   This is an area for further study. 
 
Gender and Age 
 
We found that there were no significant differences in gender or age of patients with recurrent 
diverticulitis.  Median ages across the groups were similar.   Age did not significantly affect recurrence 
rates. 
 
Surgery and Interventional Radiology  
 
There were only 15 recurrences in patient who had undergone surgery representing 4.6% of all 
patients who had undergone surgery.  There were 223 recurrences in 978 Patients who had not had 
surgery, representing 22.8% of patients.  Patients who had surgery were significantly less likely to be 
in the recurrence group (p<0.0002).  The total number of patients with recurrence after surgery was 
too small to perform subgroup analysis, but overall, there did not seem be any difference in 
emergency vs elective surgery on rate of recurrence.   
 
Our data also shows that patients who underwent surgery or an interventional radiological procedure 
had a significantly lower risk of developing recurrent diverticulitis.  We specifically excluded patients 
undergoing reversal of Hartmann's procedure from the surgery group, as this procedure was not 
related to recurrent diverticulitis.  In our study, approximately 4.7 % of all patients who underwent 
these procedures developed recurrent diverticulitis.  This is consistent with reported rates in the 
literature [3, 255, 329].   
 
There were a total of 15 recurrences out of 321 patients with surgical or radiological interventions.   If 
we look specifically at patients who had a colectomy, and then subsequently developed a recurrence 
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of diverticulitis, there were only 10 recurrences out of 287 colectomies (3.5%).  This recurrence rate 
was significantly lower than that of patients without any intervention.  Interventional radiological 
procedures seemed to have a higher recurrence rates (4 out of 24 patients, 16.6%).  This could not be 
tested for statistical significance due to low overall numbers.   
 
The median time to recurrence after surgery was 6 months for conservatively managed patients and 
9 months after surgery.  There were no significant differences in time to recurrence with or without 
surgery. 
 
Limitations of study 
 
There are several limitations to our study.  The course of diverticulitis may be affected by multiple 
other factors, including length of medical treatment, family history and environmental factors such as 
smoking [159, 266].  We did not examine the effect of these factors.  Overall, the number of patients 
with recurrent disease is small, with subgroups being even smaller.  Our study may not have sufficient 
power to detect a small difference between these subgroups.  We only looked at regular use of the 
medications studied.  The effect of intermittent use of these medications is not known.  We also 
calculated BMI and weight using morphological data obtained from CT scanning.  While this method 
is validated, there is a chance of error associated with measurement, which may result in over or 
underestimation of metrics.   
 
There may be also an additive or cumulative effect of risk factors.  For example, patients with 
autoimmune disease may also be on NSAIDS or oral corticosteroids. Because of small numbers we 
could not analyse for significant differences within these subgroups.   
 
Our definition of recurrence after surgery was very strict.  Patients with a solely clinical diagnosis of 
recurrence were excluded.  There were a number of patients who were admitted after an index 
operations with clinical and biochemical signs consistent with diverticulitis.  Radiologically however, 
there was no evidence of diverticulitis.  These were excluded.  There were also patients with colitis, 
pelvic abscesses and other pathology seen on CT, without any evidence of diverticulitis.  These were 
also excluded from recurrence.  Whether these pathologies were related to diverticulitis is debatable.  
Their effects were also excluded.  There is a chance our recurrence rate may underestimate the true 





Our study shows that patients with uncomplicated disease at initial presentation, autoimmune disease 
and regular NSAIDs are significantly more likely to have recurrent diverticulitis.  Patients who had 
surgery or an interventional radiological procedure were significantly less likely to develop recurrence.  
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Medical knowledge has advanced significantly over the past century and is increasing at an almost 
exponential rate. It was estimated that the doubling time of medical knowledge in 1950 was 50 years.  
In 2020, the doubling time of medical knowledge is projected to be just 73 days[339]. Despite this 
huge leap in knowledge, a common and prevalent condition such as Acute Diverticulitis still remains 
shrouded in mystery. 
 
The history of diverticulitis has been shrouded by incorrect assumptions, flawed methodology, and 
treatments based on very little evidence.  These historical errors led to practices which are very 
difficult and slow to change. 
 
Diverticulitis was initially only thought to affect an older age group.  Due to medical advances, life 
expectancy has increased.  Associated with this, the number of patients afflicted by diverticulitis has 
also increased.  American NIS data has shown that between 1998 and 2005, the domestic US 
population aged 18 and older grew by 9.6%.  The greatest increase was in individuals older than 75, 
by 33%[273].  In this time period, admissions for acute diverticulitis increased by 26%[273].  This trend 
is by no means restricted to United States alone.  Analysis of acute hospital admissions in New Zealand 
has shown a similar trend, with an increase from 1,443 admissions in 2001 to 2,701 admissions in 2011 
[340]. 
 
Despite advances, there remains significant heterogeneity in management of diverticulitis.  Experts 
disagree significantly on most issues.  A recent Delphi study questioned international experts on 20 
items related to management of Acute Diverticulitis[341].  Questions ranged from Definition of 
Diverticulitis, use of biochemical markers, Use of imaging, Management with antibiotics and role of 
surgery and colonoscopy.  They found that there was more non-consensus than consensus among 
experts. 
 
The pathophysiology of Acute Diverticulitis is not understood.  There are a number of risk factors 
identified that have been causally linked to Diverticular Disease and Diverticulitis. Some of these such 
as Dietary Fibre and Intraluminal Colonic Pressures have very conflicting results.  There is a significant 
lack of good quality evidence to suggest a role for this in the pathogenesis of Diverticulosis, 
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Diverticulitis or recurrence.  It is very difficult, if not impossible to accurately gauge exact dietary fibre 
intake in a general population because of significant variations in diet.  
 
Diverticular disease occurs over a long time period, and there are no studies looking at role of Dietary 
Fibre in pathogenesis of diverticulosis over a long period of time.   
 
Role of Obesity 
 
Obesity is a huge problem in Western societies.  According to the World Health Organization, obesity 
has tripled since 1975, and in 2016, 29% of adults aged 18 and over were overweight or obese[342]. 
These figures are projected to increase.  Obesity is now considered one of the most serious public 
health issues of the 21st century.  Numerous factors have contributed to this, including diet, mass 
urbanisation, sedentary lifestyles, social attitudes and societal changes etc. 
 
Obesity has long been associated with an increased risk of surgical site infection.  This association has 
been confirmed in epidemiological studies[282, 343].  This is not simply confined to abdominal surgery 
[344].  Obesity has been associated with increased morbidity and mortality with non-surgical 
infections, such as the 2009 Influenza Pandemic (H1N1)[345].   
 
Obesity has been associated with a chronic low grade inflammatory state [346, 347].  Adipose cells 
have a significant neurohormonal function, which have a role in the proliferation, maturation and 
activity of immune cells.  A study by Nieman and colleagues showed reduced lymphocyte proliferation, 
raised white cell and lymphocyte subset counts and higher monocyte and granulocyte phagocytosis in 
obese patients [348].  Another study by Ghanim and colleagues showed increased transcription of pro-
inflammatory genes in Mononuclear cells of the obese[349].  Both these suggest that immune cells of 
obese patients exist in a pro-inflammatory state. 
 
The hormonal function of adipose cells is again, only now being recognised.  Adipose cells produce 
Leptin.  Leptin is released predominantly by adipose cells and inhibits hunger to maintain energy 
balance.  It acts opposite Ghrelin, which stimulates hunger.  Both these hormones act on the 
hypothalamus[350].  Leptin has also been shown to have significant immunological function.  It has 
been shown to regulate CD4+ T cells[225].  Patients with genetic deficiency of Leptin have significant 
immune dysfunction[284].  It is associated with increased risk of infections and death from infectious 
causes, as well severe obesity. Similarly, leptin deficient murine models show reduced circulating CD4+ 
cells and impaired T cell proliferation[351].  Adiponectin is another hormone which has raised levels 
in the obese [352].   This has been shown to induce anti-inflammatory cytokines in leucocytes, 
resulting in reduced phagocytic activity in macrophages [283].  Obesity has also been linked to other 
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immunological dysfunction.  Obese patients have been shown to have a poor antibody response to 
vaccination[353].  Obese patients are also more susceptible to viral infections such as HSV1[354]   
 
Epidemiological studies have suggested a link between obesity and diverticulitis [185, 222, 223].  The 
Health Professionals Follow-up Study and the Swedish Male study showed an increase in symptomatic 
diverticular disease in patients with obesity and reduced physical activity [185, 223]. These however, 
did not specifically look at acute diverticulitis.  In a follow-up study of 47,228 health professionals by 
Strate et.al., patients with a BMI>30 had almost double the relative risk of acute diverticulitis 
compared to patients with BMI<21kg/m2 [222].   
 
While this looked at obesity and diverticulitis, to our knowledge, no study to date has looked at obesity 
in patients with diverticulitis alone.  Therefore, our data represents the largest study of Body Mass 
Index in patients with confirmed diverticulitis alone. 
 
Our data shows that overweight and obese patients are significantly over-represented in patients with 
acute diverticulitis and recurrence. Figure 1 shows percentage of obese patients in those with acute 
diverticulitis and recurrent diverticulitis against the estimated national average.  Data for national 
average was obtained from Ministry of Health National Health Survey 2014/2015 [355]. 
 
The proportion of obese patients decreases with age.  The percentage of obese patients was higher in 
every age group up to 74.  Overall, in patients with acute diverticulitis, obesity was almost double the 
national average.  Patient with recurrence seemed to have a lower proportion of obesity than patients 












Our data shows male patient were significantly more likely to be obese at index presentation of acute 
diverticulitis compared to female patients.  This trend of diverticulitis in obese males has been 
observed in other studies[103, 289].  Obese patients were also significantly more likely to have 
uncomplicated disease at presentation, with 64.7% of obese patients having uncomplicated disease, 
vs 47% of non-obese patients.  There was no significant difference in proportion of complicated and 
uncomplicated disease in the Obese and Non Obese.  Figure 2 below shows the percentage of patients 
in obese and non-obese groups against the factors studied.  There was a statistically significant 
increase in uncomplicated disease, diabetes and conservative management in the obese group at 
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Role of Surgery 
 
The results for surgery deserve further analysis.  There has been a significant shift away from elective 
surgery in patients with diverticulitis.  Traditional criteria have been for resection after 2 episodes of 
confirmed diverticulitis [325, 356].  These patients were at index presentation for diverticulitis, so 
elective surgery was not offered for this philosophy.  Of the 106 patients that underwent elective 
surgery, 77 were for persisting symptoms, 9 for stricture and obstruction, 18 for colovesical fistula and 
2 for suspicion of malignancy. 
 
Out of a total of 324 patients that underwent surgery, 306 (94.4%) underwent surgery after index 
presentation.  Only 18 patients underwent surgery after recurrences, representing only 5.9% of all 
surgery.  There were 238 recurrences, therefore, about 8% of patients with recurrence disease 
underwent elective surgery. Patients with recurrent disease were no more likely to undergo elective 
surgery than patients at index presentation.   
 
The results for emergency surgery are interesting.  Out of a total of 1299 patients, 209 (16.1%) 
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patients were significantly less likely to undergo emergency surgery.  Obese patients were also 
significantly more likely to be managed conservatively. 
 
This finding has implications for practice.  The cause of this is not clear, and could be either a different 
behaviour of the disease in obese patients, or reluctance for surgeons to operate on these patients.  
As discussed earlier, obesity results in relative immunosuppression.  Obese patients are also clinically 
more difficult to examine, and standard abdominal signs may be masked in them due to a thick body 
wall masking peritoneal signs.  It is possible that because of these factors, obese patients have a lower 
grade of disease, and may not progress the same as non-obese patients. 
 
Surgery in obese patients represents serious challenges for surgeons.  Surgery in the obese is 
associated with increased technical difficulty, and increased morbidity and mortality[292, 357]. 
Because of these reasons, it is possible that surgeons utilize a higher threshold when deciding to 
operate on these patients.  There may be desire to persist with medical management and there may 
be a reluctance to operate for fear of causing harm to patients.  This effect was only noted in patients 
at index admission.  There was no difference in proportion of emergency surgery at recurrent 
episodes. 
 
Role of NSAIDS, Corticosteroid and Other Immunosuppressive medications 
 
Non-steroidal Anti-inflammatory medications are ubiquitous in the community.  They are amongst the 
commonest pain relief medications taken in the world. NSAIDS have recognised side effects including 
loss of gastric mucosal barrier and peptic ulceration due to inhibition of cyclooxygenase mediated 
prostaglandin synthesis pathways.  They also have extra gastric effects , including small bowel and 
colonic ulcers [336].  Previous studies have causally linked use of regular Non Steroidals with an 
increased risk of diverticulitis [208, 266]. The mechanism for this is not clear.  It is possible that NSAIDS 
impair the host immune acute inflammatory response, allowing for an infection to advance and thus 
make it more likely to get diverticulitis.  It is also theoretically possible that NSAIDS damage mucosal 
barriers, allowing for translocation of bacteria and infection resulting in diverticulitis.  NSAIDS have 
been associated with increased risk of perforated diverticulitis [267, 268]. 
 
Our results on NSAIDS are somewhat conflicting.  In our study, about 34% of all patients were on a 
regular NSAID.  It is estimated that 26% of the American population used an NSAID regularly in 2004 
[265].  The use of NSAIDS was significantly higher in obese patients, patients over 60 years of age and 
women.  It would seem that our dataset is comparable to this.   We could not demonstrate a significant 
increased risk of complicated disease at index presentation.  This finding is significant, and is contrary 
to previous published findings.  The cause of this is not clear and is an area for future study.  We did, 
however, find that patients on regular NSAIDS were significantly more likely to have recurrent disease.  
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A total of 44% of patients with recurrence were regular users of NSAIDS.  Again, we could not 
demonstrate a higher incidence of complicated disease at recurrence.  NSAIDS did not have a 
significant effect on emergency surgery or type of surgery performed. 
 
Our results suggest that there may be an effect of NSAIDS in the establishment of acute diverticulitis, 
without specifically increasing the risk of perforation. 
 
When looking at corticosteroid and other immunosuppressant use, we could not demonstrate a 
significant increased risk of complicated disease, surgery or recurrence.  We attempted to divide 
patients into high dose and low dose users, and again, we could not demonstrate a statistically 
significant difference. 
 
This does seem counterintuitive.  There is some overlap between diverticulitis and inflammatory 
bowel disease, and there is a some evidence that acute diverticulitis may be a low grade inflammatory 
autoimmune colitis[358, 359].  This is the rationale for management of acute uncomplicated 
diverticulitis without antibiotics [360].  There is emerging evidence that uncomplicated diverticulitis 
can be safely managed without antibiotics[310, 361].  It is possible that steroids do not affect the 
natural history of acute diverticulitis, or if anything, treat it.  Steroids work at a cellular transcription 
level, and have more pronounced effects on chronic inflammation rather than acute inflammation.  
This may also be a potential reason as to why there is no increased risk of acute diverticulitis or 
increased risk of complicated disease.   
 
Role of Chronic Autoimmune Disease and Diabetes 
 
Chronic autoimmune diseases include collagen vascular disease, systemic vasculitidies and other 
syndromes.  These have well recognised effects on the gastrointestinal tract [362].  Rheumatoid 
arthritis, and other vasculitic arthritides has been associated with a collagenous colitis, and sometimes 
mimics inflammatory bowel disease [363].  Autoimmune diseases have also been associated with 
increased risk of bowel perforation [362] [193]. 
 
We could not demonstrate a significantly increased risk of autoimmune diseases at index presentation 
in patients with Acute Diverticulitis. There was however, a significantly higher proportion of patients 
with autoimmune disease with recurrent diverticulitis (4.6% vs 1.1%).  Patients with autoimmune 
diseases are at higher risk of recurrence.  
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Diabetes is also a condition that is prevalent in our community.  Diabetes has well documented effect 
on infections.  We hypothesized that diabetics were at increased risk of acute diverticulitis and 
recurrence.  On review of the data, we could not demonstrate a significant difference in proportion of 
patients with diabetes in uncomplicated and complicated disease, surgery and recurrence.   
 
Role of Routine Colonoscopy after Diverticulitis 
 
Traditionally, diverticulitis has been diagnosed clinically. There is a wide differential for diverticulitis, 
and it is known that up to 37% of diagnoses change with cross sectional imaging[230].  Prior to 
availability of CT scanning, Barium enema tests were used to confirm diverticular disease.  This is 
technically difficult, operator dependent and can miss up up to half of all cancers [314, 321]. This 
resulted in the practice of performing routine colonoscopy after diverticulitis to exclude a malignancy. 
 
Initial Single Slice CT scanning technology resulted in grainy images with thick slices, and while an 
improvement over existing barium enema technology, were still not up to par, and the practice of 
colonoscopy continued [364].  Technology has improved significantly since then.  Most institutions 
now have multi-slice, multi-detector CT Scanners, which allow for thinner slices at greater 
resolution[323, 365].  This allows for better evaluation of the colon.  
 
There is also recognition that uncomplicated diverticulitis may not have the same natural history as 
complicated disease.  Uncomplicated diverticulitis is defined as the presence of colonic diverticular 
disease with localised wall thickening and/or stranding of pericolic fat on CT. Complicated diverticulitis 
is defined as; the presence of abscess, perforation (including any pericolic or extraluminal gas), 
obstruction or fistula formation, protracted disease with symptoms, or an associated mass lesion. 
 
Previous studies looking at uncomplicated diverticulitis showed a low rate of malignancy[309, 310].  
We performed a Systematic Review and Meta-analysis of all studies with radiologically confirmed 
diverticulitis and attempted to quantify the risk.  This was published in Annals of Surgery [366].  We 
found that the risk of malignancy after uncomplicated disease was 1.6% and the risk after complicated 
disease was 10.8%.  Comparing this to a large screening study on a asymptomatic individuals, we 
showed that the risk of malignancy after uncomplicated diverticulitis was not different to that of the 
general population [316]. 
 
Since the publication of our study in 2014, the finding of a low risk in uncomplicated diverticulitis 
equivalent to that of the general population, and a much higher risk in complicated diverticulitis has 
been shown in multiple studies, confirming our findings[367-370].  There have been at least 2 large 
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studies confirming our findings [371, 372].  This study has been included in evidence for recent 
guidelines [373].  
 
Our study has resulted in a change in practice at our institution (Christchurch Public Hospital), and has 
also resulted in change in practice in Helsinki University Central Hospital [374].  There may be a wider 
change in practice which has not been published in literature.   A recent Delphi study tried to find 
consensus amongst experts around the world for management of diverticulitis [341].  On most 
aspects, there was more non-consensus than consensus on issues to do with management of 
diverticulitis.  On the issue of colonoscopy, however, there was consensus that colonoscopy was not 
needed for every patient, and a selective approach can be employed.  Our study was cited as high 






Obese patients are significantly overrepresented in patients with diverticulitis and recurrence.  Obese 
patient were significantly more likely to be managed conservatively and were significantly less likely 
to undergo emergency surgery.  Male patients were significantly more likely to be obese at index 
presentation.   
 
Factors not associated with an increased risk of complicated diverticulitis at index presentation include 
obesity, NSAIDS, Corticosteroid and immunosuppressive medications, Chronic autoimmune diseases, 
diabetes, age and gender. 
 
Factors associated with an increased risk of recurrent diverticulitis include regular NSAID use, 
Autoimmune disease, and uncomplicated disease at index presentation. Obesity was not associated 
with an increased risk of recurrence.  
 
The only factor associated with a decreased risk of recurrent diverticulitis was surgery.  There was no 
difference whether the surgery was emergency or elective surgery.  The risk of recurrent diverticulitis 
decreased with each recurrence.  Greater than 3 recurrences are rare.  Surgery cannot be justified 
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